<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD with OASIS Tables v1.0 20120330//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing-oasis-article1.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName jpoasis-nisons2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Drug Deliv</journal-id><journal-id journal-id-type="iso-abbrev">Drug Deliv</journal-id><journal-id journal-id-type="publisher-id">IDRD</journal-id><journal-id journal-id-type="publisher-id">idrd20</journal-id><journal-title-group><journal-title>Drug Delivery</journal-title></journal-title-group><issn pub-type="ppub">1071-7544</issn><issn pub-type="epub">1521-0464</issn><publisher><publisher-name>Taylor &#x00026; Francis</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6968485</article-id><article-id pub-id-type="pmid">31913733</article-id><article-id pub-id-type="doi">10.1080/10717544.2019.1709920</article-id><article-id pub-id-type="publisher-id">1709920</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Preparation, evaluation and metabolites study in rats of novel
amentoflavone-loaded TPGS/soluplus mixed nanomicelles</article-title><alt-title alt-title-type="running-authors">X. Feng et al.</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Feng</surname><given-names>Xue</given-names></name><xref ref-type="aff" rid="AF0001">
<sup>a</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Yuting</given-names></name><xref ref-type="aff" rid="AF0001">
<sup>a</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Luya</given-names></name><xref ref-type="aff" rid="AF0001">
<sup>a</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Yuqian</given-names></name><xref ref-type="aff" rid="AF0002">
<sup>b</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Lantong</given-names></name><xref ref-type="aff" rid="AF0001">
<sup>a</sup>
</xref><xref ref-type="corresp" rid="AN0001"/></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Zhiqing</given-names></name><xref ref-type="aff" rid="AF0002">
<sup>b</sup>
</xref><xref ref-type="corresp" rid="AN0002"/></contrib><aff id="AF0001"><label>a</label><institution>Department of Pharmaceutical Analysis, School
of Pharmacy, Hebei Medical University</institution>, Shijiazhuang, <country>PR
China</country>; </aff><aff id="AF0002"><label>b</label><institution>The Second Hospital of Hebei Medical
University</institution>, Shijiazhuang, <country>PR China</country></aff></contrib-group><author-notes><fn id="AUFN1"><p>Supplemental data for this article can be accessed <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1080/10717544.2019.1709920"><underline>here</underline></ext-link>.</p></fn><corresp id="AN0001"><bold>CONTACT</bold> Lantong Zhang <email>zhanglantong@263.net</email><institution>Department of Pharmaceutical Analysis, School of Pharmacy, Hebei Medical
University</institution>, <addr-line>No. 361, Zhongshan Road</addr-line>, Shijiazhuang,
050017, <country>China</country>;</corresp><corresp id="AN0002">Zhiqing Zhang <email>777yyy@sina.cn</email><institution>The Second Hospital of Hebei Medical University</institution>, Shijiazhuang,
050000, <country>PR China</country></corresp></author-notes><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>8</day><month>1</month><year>2020</year></pub-date><volume>27</volume><issue>1</issue><fpage seq="12">137</fpage><lpage>150</lpage><history><date date-type="received"><day>28</day><month>10</month><year>2019</year></date><date date-type="rev-recd"><day>18</day><month>12</month><year>2019</year></date><date date-type="accepted"><day>24</day><month>12</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; 2020 The Author(s). Published by Informa UK Limited, trading as
Taylor &#x00026; Francis Group.</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>The Author(s)</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted
use, distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="IDRD_27_1709920.pdf"/><abstract><title>Abstract</title><p>Amentoflavone (AMF) is a kind of biflavonoids existing in Ginkgo biloba leaves. It has
many biological activities, such as antioxidant, anti-inflammatory, anti-bacterial,
antiviral, hypoglycemic, anti-tumor and inducing apoptosis. However, its solubility and
bioavailability are poor and there are a few studies on it <italic>in&#x000a0;vivo</italic>. In
this study, to improve its solubility and bioavailability, the nanomicelles were prepared
with TPGS and soluplus as carriers for the first time. The particle size, Zeta potential,
encapsulation efficiency, drug loading, stability, cytotoxicity, cellular uptake, and
metabolites in rats were studied. Cytotoxicity, cellular uptake, and metabolites in rats
of AMF-loaded TPGS/soluplus mixed micelles were compared with those of AMF. As a result,
AMF-loaded TPGS/soluplus mixed micelles with a particle size of 67.33&#x02009;&#x000b1;&#x02009;2.01&#x02009;nm and Zeta
potential of &#x02212;0.84133&#x02009;&#x000b1;&#x02009;0.041405&#x02009;mV were successfully prepared. The encapsulation
efficiency and drug loading of the mixed nanomicelles were 99.18&#x02009;&#x000b1;&#x02009;0.76% and 2.47&#x02009;&#x000b1;&#x02009;0.01%,
respectively. The physical and chemical properties of the mixed micelles were stable
within 60 d, and the cytotoxicity of the mixed micelles was much greater than that of AMF
monomers. Thirty-four kinds of metabolites of AMF were identified in rats. The metabolites
were mainly distributed in rat feces. No metabolites were detected in bile and plasma. 14
kinds of metabolites of the mixed micelles in rats were detected, including 11 in feces, 6
in urine, and 3 in plasma, which indicated that the bioavailability of AMF has been
improved. And the toxicity to cancer cells was enhanced, which laid a foundation for the
development of new drugs.</p></abstract><kwd-group kwd-group-type="author"><title>Keywords</title><kwd>Amentoflavone</kwd><kwd>nanomicelle</kwd><kwd>cytotoxicity</kwd><kwd>cellular uptake</kwd><kwd>metabolite</kwd><kwd>UHPLC-Q/TOF-MS</kwd></kwd-group><funding-group><award-group><funding-source><named-content content-type="funder-name">National Natural Science Foundation of
China</named-content><named-content content-type="funderidentifier">10.13039/501100001809</named-content></funding-source></award-group><funding-statement>This project was financially supported by the National Natural Science
Foundation of China [No. 81473180].</funding-statement></funding-group><counts><fig-count count="10"/><table-count count="4"/><page-count count="14"/><word-count count="8899"/></counts></article-meta></front><body><sec id="s0001"><label>1.</label><title>Introduction</title><p>Ginkgo is a deciduous tree of ginkgo family and ginkgo genus. It is an ancient gymnosperm
with a growth history of several hundred million years (Gong et&#x000a0;al., <xref rid="CIT0010" ref-type="bibr">2008</xref>). Ginkgo biloba leaves are rich in more than 200 kinds of
compounds such as lactones, polysaccharides, flavones, organic acids and phenolic acids (Ude
et&#x000a0;al., <xref rid="CIT0034" ref-type="bibr">2013</xref>). Biflavonoids as special
flavonoids, their activities are higher than that of monoflavonoids in some aspects.
Therefore, a more detailed study on biflavonoids has a good application prospect and
significance. As a kind of biflavonoids in ginkgo biloba leaves, amentoflavone (AMF) has
many biological activities, such as antioxidant (Zhang et&#x000a0;al., <xref rid="CIT0044" ref-type="bibr">2015</xref>; Lee &#x00026; An, <xref rid="CIT0021" ref-type="bibr">2016</xref>),
anti-inflammatory (Zhang et&#x000a0;al., <xref rid="CIT0044" ref-type="bibr">2015</xref>),
antifungal (Hwang et&#x000a0;al., <xref rid="CIT0016" ref-type="bibr">2012</xref>), antiviral
(Coulerie et&#x000a0;al., <xref rid="CIT0006" ref-type="bibr">2013</xref>), hypoglycemic (Su et&#x000a0;al.,
<xref rid="CIT0032" ref-type="bibr">2019</xref>), anti-tumor (Guruvayoorappan &#x00026;
Kuttan, <xref rid="CIT0013" ref-type="bibr">2008</xref>), and inducing apoptosis (Pei
et&#x000a0;al., <xref rid="CIT0028" ref-type="bibr">2012</xref>; Zhaohui et&#x000a0;al., <xref rid="CIT0048" ref-type="bibr">2018</xref>).</p><p>Studies have shown that the metabolism and elimination of AMF in rats are fast, and the
bioavailability of AMF by intraperitoneal injection was 77.4%&#x000b1; 28%, but the oral
bioavailability is very low (Liao et&#x000a0;al., <xref rid="CIT0023" ref-type="bibr">2015</xref>;
Yu et&#x000a0;al., <xref rid="CIT0041" ref-type="bibr">2017</xref>). Researches on the tissue
distribution of AMF in rats showed that after oral administration, the drugs are mainly
distributed in the small intestine and stomach, followed by the liver and large intestine,
and only a small part can enter other tissues with blood circulation. And it is difficult to
dissolve in water and organic solvents, so it is difficult to be absorbed by the body. To
give full play to the pharmacological effects of AMF, bioavailability and solubility must be
improved. The main methods to improve the bioavailability and solubility of drugs are to
change the way of drug delivery, change the dosage form (Wei et&#x000a0;al., <xref rid="CIT0037" ref-type="bibr">2014</xref>; Hu et&#x000a0;al., <xref rid="CIT0015" ref-type="bibr">2017</xref>;
Santos et&#x000a0;al., <xref rid="CIT0029" ref-type="bibr">2019</xref>) or modify its structure (Sen
Gupta &#x00026; Ghosh, <xref rid="CIT0030" ref-type="bibr">2017</xref>). Because it is difficult
for AMF to dissolve in water and organic solvents, it is almost impossible to change the way
drugs are administered. In recent years, micelle-based drug delivery systems have been
widely developed because of their enhanced pharmacokinetics, biological distribution and
high stability (Kesharwani et&#x000a0;al., <xref rid="CIT0019" ref-type="bibr">2018</xref>; Zhang
et&#x000a0;al., <xref rid="CIT0046" ref-type="bibr">2019</xref>), and oral bioavailability has been
greatly improved after the preparation of micelles (Guo et&#x000a0;al., <xref rid="CIT0011" ref-type="bibr">2017</xref>). So in this experiment, the nanomicelle was made, and evaluated
<italic>in&#x000a0;vitro</italic> and <italic>in&#x000a0;vivo</italic>.</p><p>As everyone knows, when a drug enters the body, a series of metabolites are produced, and
then excreted in urine and feces. In the series of biotransformation processes, there are
four aspects of pharmacological consequences: (1) transforming into inactive substances; (2)
transforming the drug with no pharmacological activity into active metabolites; (3) changing
the types of pharmacological actions of drugs; (4) producing toxic substances (Yuan et&#x000a0;al.,
<xref rid="CIT0042" ref-type="bibr">2014</xref>; Liao et&#x000a0;al., <xref rid="CIT0022" ref-type="bibr">2018</xref>). Therefore, it plays an important role to study the changes of
drugs <italic>in&#x000a0;vivo</italic> to make sure the safe and rational use of new drugs. In
addition, the study of metabolites can also reflect the absorption of drugs in the body. In
this experiment, the metabolites of the biflavone were analyzed in detail, which laid a
foundation for the pharmacological research and the development of new drugs.</p><p>Mixed micelles are self-assembled micelles of two or more chemical materials and drugs with
nano-size. Mixed micelles have many advantages over single micelles. First, they can
encapsulate drugs in the core region to prevent degradation of drugs by external substances,
such as gastric acid and cytochrome P450, resulting in the improvement of their stability
(Nishiyama &#x00026; Kataoka, <xref rid="CIT0026" ref-type="bibr">2006</xref>; Chiappetta &#x00026;
Sosnik, <xref rid="CIT0005" ref-type="bibr">2007</xref>). Second, these carriers are
nanostructures formed by self-assembly of amphiphilic copolymers in aqueous media, exposing
hydrophilic tails outside and hiding the hydrophobic head in the core region. Consequently,
the solubility of hydrophobic drugs is increased (Moretton et&#x000a0;al., <xref rid="CIT0024" ref-type="bibr">2014</xref>). Third, the mixed micelle system can reduce the inconsistency
and nonspecific uptake of reticuloendothelial system, and enhance the targeting of drugs by
enhancing permeability and retention effect (Gaucher et&#x000a0;al., <xref rid="CIT0008" ref-type="bibr">2005</xref>). In addition, the mixed micelles range from 20 to 200&#x02009;nm is
large enough to avoid rapid elimination of renal tubules, and also small enough to penetrate
blood vessels, enhance drug targeting and reduce toxicity to nonspecific organs. Besides,
mixed micelles can also reduce adverse effects of drugs, increase drug loading and delay
drug release, so they have been widely used in recent years, which has considerable research
prospects (Bernabeu et&#x000a0;al., <xref rid="CIT0002" ref-type="bibr">2016</xref>; Xu et&#x000a0;al.,
<xref rid="CIT0039" ref-type="bibr">2016</xref>).</p><p>In recent years, researchers have studied a large number of mixed micelles by combining the
outstanding advantages of different types of single micelles (Jain &#x00026; Kumar, <xref rid="CIT0017" ref-type="bibr">2010</xref>; Jiang et&#x000a0;al., <xref rid="CIT0018" ref-type="bibr">2019</xref>). In this study, polyvinyl caprolactam&#x02013;polyvinyl
acetate&#x02013;polyethylene glycol graft copolymer (soluplus) and <sc>d</sc>-&#x003b1;-tocopheryl
polyethylene glycol 1000 succinate (TPGS) were used as carriers to prepare mixed micelles of
AMF. Soluplus has good solubilization for the drugs with poor water solubility, and can
reduce the critical micellar concentration (CMC) value (0.76&#x02009;&#x000d7;&#x02009;10&#x02013;3% w/v) and increase the
drug loading (Bernabeu et&#x000a0;al., <xref rid="CIT0002" ref-type="bibr">2016</xref>; Hou et&#x000a0;al.,
<xref rid="CIT0014" ref-type="bibr">2019</xref>). However, in recent years, there are few
studies on soluplus to improve the solubility of drugs, so the research prospect of soluplus
is very broad. TPGS is widely used in the preparation of pharmaceutical formulation products
as solubilizing agent, granulation aid, emulsifying agent, surfactant, ointment base, and
suspending agent in pharmaceuticals (Guo et&#x000a0;al., <xref rid="CIT0012" ref-type="bibr">2013</xref>; Koulouktsi et&#x000a0;al., <xref rid="CIT0020" ref-type="bibr">2019</xref>). And
there were also researches showed that it can inhibit the effect of P-gp, and promote cell
apoptosis and show certain toxicity to cancer cells (Varma &#x00026; Panchagnula, <xref rid="CIT0035" ref-type="bibr">2005</xref>; Neophytou et&#x000a0;al., <xref rid="CIT0025" ref-type="bibr">2014</xref>; Bernabeu et&#x000a0;al., <xref rid="CIT0002" ref-type="bibr">2016</xref>).</p><p>Nanoparticle drugs of oral administration have to overcome the mucosal diffusion barrier
and epithelial absorption barrier except ensure their integrity in the gastrointestinal
tract. This requires the particle surface relatively electro-neutral and have a particle
size of less than 200&#x02009;nm (Wu et&#x000a0;al., <xref rid="CIT0038" ref-type="bibr">2019</xref>).
Therefore, this experiment was dedicated to the preparation of mixed nanomicelles with
electro-neutral surface, a particle size of less than 200&#x02009;nm, high solubility, and good
stability. Due to its low content in nature, the current research on AMF was mainly limited
to its pharmacological activity, less research on its <italic>in&#x000a0;vivo</italic> process, and
no research on its preparation. Therefore, this experiment would fill the gaps in these
aspects.</p><p>Recently, cancer is one of the most common lethal diseases in the world. The main treatment
methods are surgery, chemotherapy and radiotherapy. But the treatment results are not
completely satisfactory, the cure rate and the life quality of patients is low. In these
days, researchers all over the word make every effort to develop new drugs that can treat
cancer effectively. AMF is a biflavonoids composed of two molecules of apigenin by C&#x02013;C
bonds. Due to its low toxicity to normal cells and its anti-cancer effect, it is expected to
have a better effect in the treatment of cancer. Because nanomedicines have good targeting
and good solubility in the treatment of cancer, the preparation of nanomicelles with low
toxicity to normal cells into nanomicelles can reduce side effects and enhance drug
stability, prolong the release time and can also increases its targeting and toxicity to
cancer cells (Wan et&#x000a0;al., <xref rid="CIT0036" ref-type="bibr">2018</xref>), so it has a good
development prospect.</p></sec><sec id="s0002"><label>2.</label><title>Materials and methods</title><sec id="s0003"><label>2.1.</label><title>Instruments</title><p>Triple TOF&#x02122; 5600&#x02009;+&#x02009;high resolution tandem mass spectrometry (AB SCIEX, Redwood City, CA);
Ultra-high performance liquid chromatography system (Shimazhu 20A, Shimadzu Corporation,
Tokyo, Japan); D3024R bench refrigerated centrifuge (Beijing Dalong Co., Ltd., Beijing,
China); EYELLA N1100 rotary evaporator (Tokyo Rikakikai Co., Ltd., Tokyo, Japan);
Ultrasonic crushing instrument (Wuxi Voshin instruments Manufacturing Co., Ltd., Huishan,
China); Nano-ZS particle size tester (Malvern Instruments, Worcestershire, UK);
Ultimate3000 high performance liquid chromatography (Thermo Fisher Scientific, Waltham,
MA); pectraMax Plus384 Molecular Devices (Molecular Devices, Silicon Valley, CA); HF240
cell culture box (Shanghai Lishen Scientific Instrument Co., Ltd., Shanghai, China);
SW-CJ-2FD clean bench (Suzhou Antai Airtech Co., Ltd, Beijing, China); T9S dual-beam
ultraviolet-visible spectrophotometer (Beijing Persee General Instrument Co., Ltd,
Beijing, China); FV1200MPE laser confocal microscope (Olympus, Tokyo, Japan).</p></sec><sec id="s0004"><label>2.2.</label><title>Chemicals and materials</title><p>AMF (18040241, purity &#x0003e; 98%) was purchased from Shanghai Shifeng Biological Technology
Co., Ltd., Shanghai, China. Soluplus was purchased from BASF (Ludwigshafen, Germany).
Vitamin E polyethylene glycol succinate (TPGS) was purchased from Shanghai Yuanye
Bio-Technology Co., Ltd., Shanghai, China. HPLC-grade methanol and acetonitrile were
purchased from American <italic>J.</italic>T.-Baker Chemical Company (Phillipsburg, NJ).
HPLC-grade formic acid was provided by Diamond Technology (Dikma Technologies Inc., Lake
Forest, CA). CCK-8 was purchased from Beijing Zoman Biotechnology Co., Ltd., Beijing,
China. Dimethyl sulphoxide (DMSO), iodine (I<sub>2</sub>), potassium iodide (KI) and
sodium carboxymethyl cellulose (CMC-Na) were purchased from Tianjin Yongda Reagent Co.,
Ltd., Tianjin, China. Pure water was purchased from Hangzhou Wahaha Group Co., Ltd.,
Zhejiang, China.</p></sec><sec id="s0005"><label>2.3.</label><title>Methods</title><sec id="s0006"><label>2.3.1.</label><title>Preparation of mixed micelle</title><p>The preparation of AMF-loaded TPGS/soluplus mixed micelles was carried out by membrane
hydration method (Zhao et&#x000a0;al., <xref rid="CIT0047" ref-type="bibr">2017</xref>).
Briefly, AMF (2&#x02009;mg), soluplus (60&#x02009;mg), and TPGS (20&#x02009;mg) were dissolved in 20&#x02009;mL methanol
in a round bottom flask. Then, the solvent was evaporated by rotary evaporation to
obtain a thin film. Subsequently, 8&#x02009;mL water was added in the round bottom flask and
hydration by ultrasonic for 1&#x02009;h to obtain a clear micelle solution. After that, it was
ultrasonic crushed for 5&#x02009;min. Finally, the micelles were filtered with 0.22&#x02009;&#x003bc;m filter
membrane to remove unencapsulated drug. The blank micelles were prepared by the same
method.</p></sec><sec id="s0007"><label>2.3.2.</label><title>Determination of critical micelle concentration (CMC)</title><p>The critical micelle concentration (CMC) is an important indicator for evaluating the
stability of micelles. The lower the CMC, the more stable the nanomicelles. In this
experiment, the CMC of AMF-loaded TPGS/soluplus mixed nanomicelles was measured using
the iodine hydrophobic probe method and determined by an ultraviolet spectrophotometer.
To prepare I<sub>2</sub>/KI standard solutions, 0.5&#x02009;g of I<sub>2</sub> and 1&#x02009;g of KI
were dissolved in 50&#x02009;mL of deionized water. Then different ratios of TPGS/soluplus
solutions with a concentration of 0.00001&#x02013;0.2% were prepared, and 25&#x02009;&#x003bc;L of
I<sub>2</sub>/KI standard solution was added to each sample. Next, the mixtures were
equilibrated at room temperature for 12&#x02009;h in the dark. Finally, the ultraviolet
absorbance value of each variant polymer concentrations were measured at 366&#x02009;nm by a UV
spectrophotometer. Plot the absorption intensity against the logarithm of the polymer
mass concentration. When the absorbance increased sharply, the concentration of the
micelle carrier was equivalent to the CMC value of the nanomicelle (Zhao et&#x000a0;al., <xref rid="CIT0047" ref-type="bibr">2017</xref>; Ding et&#x000a0;al., <xref rid="CIT0007" ref-type="bibr">2018</xref>).</p></sec><sec id="s0008"><label>2.3.3.</label><title>Particle size and zeta potential analysis</title><p>The particle size and Zeta potential of AMF-loaded TPGS/soluplus mixed micelles were
measured by dynamic light scattering technique, and each sample was measured in
triplicate. The results were expressed as mean size&#x02009;&#x000b1;&#x02009;standard deviation (SD) for three
separate experiments.</p></sec><sec id="s0009"><label>2.3.4.</label><title>Drug loading and encapsulation efficiency</title><p>The encapsulation efficiency (EE) and drug loading (DL) were determined by HPLC. A
chromatographic column (ZORBAX SB-C18, 5&#x02009;&#x003bc;m, 4.6&#x02009;mm &#x000d7; 150&#x02009;mm, Agilent, Palo Alto, CA)
was used. The mobile phases were water (A, 0.1% of formic acid) and acetonitrile (B),
and the flow rate was 1&#x02009;mL/min. Gradient elution was adopted and the elution procedure
was as follows: 35&#x02013;45% B (0&#x02013;10&#x02009;min), 45&#x02013;35% B (10&#x02013;10.1&#x02009;min), and 35% B (10.1&#x02013;15&#x02009;min).
The sample was injected at a volume of 20&#x02009;&#x003bc;L and the detection wavelength was
338&#x02009;nm.</p><p><italic>For the EE determination</italic>: the prepared mixed micelles solution
(200&#x02009;&#x003bc;L) was dissolved in 2&#x02009;mL methanol, and then treated with ultrasonic for 10&#x02009;min to
release the encapsulated drug. The solution was then centrifuged twice at
21,380&#x000d7;<italic>g</italic> for 10&#x02009;min. Take the supernatant sample for analysis.</p><p><italic>For the DL determination</italic>: The prepared micelle solution was
freeze-dried. And 45&#x02009;mg of the powder was dissolved in 1&#x02009;mL water. Subsequently, 200&#x02009;&#x003bc;L
the solution was added to 2&#x02009;mL methanol, and then treated with ultrasonic for 10&#x02009;min.
The solution was then centrifuged twice at 21,380&#x000d7;<italic>g</italic> for 10&#x02009;min. Take
the supernatant sample for analysis: <disp-formula id="M0002"><alternatives><graphic xlink:href="IDRD_A_1709920_M0002.jpg" position="float" orientation="portrait"/><mml:math id="d1e655"><mml:mrow><mml:mtext>EE</mml:mtext><mml:mi>%</mml:mi><mml:mtext>&#x000a0;</mml:mtext><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mrow><mml:mtext>&#x000a0;W</mml:mtext></mml:mrow></mml:mrow><mml:mrow><mml:mtext>AMF</mml:mtext></mml:mrow></mml:msub><mml:mo>/</mml:mo><mml:msub><mml:mrow><mml:mtext>W</mml:mtext></mml:mrow><mml:mrow><mml:mtext>AMF</mml:mtext></mml:mrow></mml:msub><mml:mo>&#x02019;</mml:mo><mml:mo>&#x000d7;</mml:mo><mml:mtext>100</mml:mtext><mml:mi>%</mml:mi></mml:mrow></mml:math></alternatives></disp-formula>
<disp-formula id="M0001"><alternatives><graphic xlink:href="IDRD_A_1709920_M0001.jpg" position="float" orientation="portrait"/><mml:math id="d1e697"><mml:mrow><mml:mtext>DL</mml:mtext><mml:mi>%</mml:mi><mml:mi>&#x000a0;</mml:mi><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mrow><mml:mi>&#x000a0;</mml:mi><mml:mi mathvariant="normal">W</mml:mi></mml:mrow></mml:mrow><mml:mrow><mml:mtext>AMF</mml:mtext></mml:mrow></mml:msub><mml:mo>/</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="normal">W</mml:mi></mml:mrow><mml:mrow><mml:mtext>micelle</mml:mtext></mml:mrow></mml:msub><mml:mo>&#x000d7;</mml:mo><mml:mn>100</mml:mn><mml:mi>%</mml:mi></mml:mrow></mml:math></alternatives></disp-formula>
(Zhai et&#x000a0;al., <xref rid="CIT0043" ref-type="bibr">2013</xref>; Yan et&#x000a0;al., <xref rid="CIT0040" ref-type="bibr">2016</xref>).</p><p>W<sub>AMF</sub> is the weight of drug in micelles; W<sub>AMF</sub>&#x02019; is the weight of
feeding drug; W<sub>micelle</sub> is the total weight of feeding soluplus, TPGS, and
drug in micelles.</p></sec><sec id="s0010"><label>2.3.5.</label><title>Optimization of preparation conditions</title><p>Because the ratio of drugs and excipients has a great influence on the particle size,
encapsulation efficiency, and drug loading of the micelle, the ratio of AMF and
excipients was optimized in this experiment. Particle size, PDI, Zeta potential, and
encapsulation efficiency were used as the indexes. The results are shown in <xref rid="t0001" ref-type="table">Table 1</xref>.</p><table-wrap id="t0001" orientation="portrait" position="float"><label>Table 1.</label><caption><p>Characteristics of AMF-loaded TPGS/Soluplus mixed micelles prepared by different
ratios of soluplus and TPGS.</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/></colgroup><thead><tr><th align="left">AMF:TPGS:soluplus</th><th align="center">Size (nm)</th><th align="center">PDI</th><th align="center">Zeta (mV)</th><th align="center">EE (%)</th></tr></thead><tbody valign="top"><tr><td align="left">1:10:20</td><td align="char" char=".">97.72&#x02009;&#x000b1;&#x02009;0.74</td><td align="char" char=".">0.253&#x02009;&#x000b1;&#x02009;0.001</td><td align="char" char=".">&#x02212;1.86&#x02009;&#x000b1;&#x02009;0.26</td><td align="char" char=".">23.52&#x02009;&#x000b1;&#x02009;0.67</td></tr><tr><td align="left">1:10:30</td><td align="char" char=".">67.33&#x02009;&#x000b1;&#x02009;2.01</td><td align="char" char=".">0.081&#x02009;&#x000b1;&#x02009;0.021</td><td align="char" char=".">&#x02212;0.84&#x02009;&#x000b1;&#x02009;0.04</td><td align="char" char=".">99.18&#x02009;&#x000b1;&#x02009;0.76</td></tr><tr><td align="left">1:10:40</td><td align="char" char=".">65.35&#x02009;&#x000b1;&#x02009;1.14</td><td align="char" char=".">0.057&#x02009;&#x000b1;&#x02009;0.032</td><td align="char" char=".">&#x02212;0.10&#x02009;&#x000b1;&#x02009;0.12</td><td align="char" char=".">98.45&#x02009;&#x000b1;&#x02009;0.85</td></tr><tr><td align="left">1:10:50</td><td align="char" char=".">67.80&#x02009;&#x000b1;&#x02009;2.89</td><td align="char" char=".">0.066&#x02009;&#x000b1;&#x02009;0.025</td><td align="char" char=".">0.13&#x02009;&#x000b1;&#x02009;0.29</td><td align="char" char=".">94.15&#x02009;&#x000b1;&#x02009;0.40</td></tr></tbody></table></table-wrap></sec><sec id="s0011"><label>2.3.6.</label><title>Micelle stability</title><p>To test the optimal formulation&#x02019;s storage stability, the AMF-loaded TPGS/soluplus mixed
micelles was stored at 4&#x02009;&#x000b0;C for 60 d. Particle size, PDI, Zeta potential, and
encapsulation efficiency of the drug-loaded micelles were measured at 0 d, 15 d, 30 d
and 60 d, respectively, and the clarification of the micelles was observed.</p></sec><sec id="s0012"><label>2.3.7.</label><title>Cell culture</title><p>A549 cells were used in the cytotoxicity and cellular uptake experiments of the
AMF-loaded TPGS/soluplus mixed micelles. A549 cells were cultured in F-12 medium
containing 1% penicillin&#x02013;streptomycin and 10% fetal bovine serum. And the cells were
maintained in an incubator at 37&#x02009;&#x000b0;C in a humidified atmosphere of 5% CO<sub>2</sub>.</p></sec><sec id="s0013"><label>2.3.8.</label><title><italic>In vitro</italic> cytotoxicity</title><p><italic>In vitro</italic> cytotoxicity of AMF-loaded TPGS/soluplus mixed micelles was
determined using the CCK-8 assay. The cells were seeded in 96-well plates at a density
of 5000 cells/well, and incubated 24&#x02009;h to allow cell attachment. After 24&#x02009;h, the
original medium was sucked out. Then, the cells were incubated with AMF and AMF-loaded
TPGS/soluplus mixed micelles of different concentration. The concentrations of AMF was
ranged from 2000&#x02009;&#x003bc;g/mL to 15.6&#x02009;&#x003bc;g/mL, and AMF-loaded TPGS/soluplus mixed micelles ranged
from100&#x02009;&#x003bc;g/mL to 0.78&#x02009;&#x003bc;g/mL. The cells were incubated for another 24&#x02009;h. And then the
medium was removed, fresh medium and CCK-8 (10&#x02009;&#x003bc;L) were added and the cells were
incubated for 2&#x02009;h. Finally, the absorbance at 450&#x02009;nm was measured using a microplate
reader, and each treatment was measured for three times (Bernabeu et&#x000a0;al., <xref rid="CIT0002" ref-type="bibr">2016</xref>).</p></sec><sec id="s0014"><label>2.3.9.</label><title><italic>In vitro</italic> cellular uptake</title><p>To evaluate the cellular uptake of AMF and AMF-loaded TPGS/soluplus mixed micelles, AMF
collected from A549 cell was determined by HPLC. Briefly, A549 cells were seeded in
6-well plates at the density of 5&#x02009;&#x000d7;&#x02009;10<sup>5</sup> cells/well and allowed to attach for
24&#x02009;h at 37&#x02009;&#x000b0;C in CO<sub>2</sub>. The original medium was removed, and each well was
washed with PBS for three times. Then AMF and AMF-loaded TPGS/soluplus mixed micelles
were added at the concentration of 30&#x02009;&#x003bc;g/mL and the cells were incubated for 1&#x02009;h, 2&#x02009;h,
4&#x02009;h and 6&#x02009;h, respectively. Untreated cells acted as control. At predetermined
time-points, the medium was removed and the cells were rinsed with PBS. Then 0.25&#x02009;mL
trypsin was added to digest the cells. When the cells are digested, they were collected
in EP tube and centrifuged at 157&#x02009;&#x000d7;&#x02009;g for 5&#x02009;min. The supernatant was removed and the
cells were resuspend with 200&#x02009;&#x003bc;L PBS. The cells were broken with ultrasonic for 5&#x02009;min
and centrifuged at 21,380&#x02009;&#x000d7;&#x02009;g for 10&#x02009;min. AMF content in the supernatant was measured by
HPLC method and the protein content was also determined using BCA protein assay kit
according to the manufacturer&#x02019;s protocol. All experiments were repeated in triplicate
(Bernabeu et&#x000a0;al., <xref rid="CIT0002" ref-type="bibr">2016</xref>).</p><p>Cell uptake of AMF&#x02009;=&#x02009;Intracellular AMF concentration (&#x003bc;g/mL)/intracellular protein
concentration (mg/mL)</p><p>In the study, to analyze the results of cellular uptake more comprehensively, a visual
qualitative analysis was carried out. The detail method was as follows: A549 cells with
good growth status were seeded in 4&#x000d7; culture dishes at 1.5&#x02009;&#x000d7;&#x02009;10<sup>5</sup> cells/well,
cultured overnight at 37&#x02009;&#x000b0;C for 24&#x02009;h. Then the old medium was removed and washed with
PBS for three times. Add the prepared culture medium with the drug concentration at
30&#x02009;&#x003bc;g/mL, and continue to culture at 37&#x02009;&#x000b0;C for 1&#x02009;h, 2&#x02009;h, 4&#x02009;h and 6&#x02009;h. The fluorescence
intensity of cells was observed under the laser confocal microscope at different time
points. The intensity of fluorescence represented the amount of drug intake.</p></sec><sec id="s0015"><label>2.3.10.</label><title>Metabolite analysis of AMF and AMF-loaded TPGS/soluplus mixed micelles</title><sec id="s0016"><label>2.3.10.1.</label><title>Instrumentation and conditions</title><p>UHPLC was performed on Shimazu&#x02019;s ultra-high performance liquid chromatography system
(Kyoto, Japan), which was equipped with a triple TOF&#x02122; 5600<sup>+</sup> MS/MS system
(AB SCIEX, Redwood City, CA). The chromatographic separation was carried on Poroshell
120 EC-C18 (2.1&#x02009;&#x000d7;&#x02009;100&#x02009;mm, 2.7&#x02009;&#x003bc;m) with a Security Guard&#x000ae; UHPLC C<sub>18</sub>
pre-column (Poroshell). The mobile phases were water (A, 0.1% formic acid) and
acetonitrile (B), and the elution procedures were as follows: 2 0&#x02013;36% B (0&#x02013;5&#x02009;min), 3
6&#x02013;59% B (5&#x02013;14&#x02009;min), 59&#x02013;73% B (1 4&#x02013;18&#x02009;min), 73&#x02013;95%B (18&#x02013;21&#x02009;min), and 95% B (21&#x02013;25&#x02009;min).
The flow rate was 0.3&#x02009;mL/min and the injection volume was 2&#x02009;&#x003bc;L. The column temperature
was 40&#x02009;&#x000b0;C, and the automatic injector temperature was 4&#x02009;&#x000b0;C.</p><p>A Triple TOF&#x02122; 5600 system with Duo-Spray&#x02122; ion sources operating in the negative
electrospray ionization mode was used for the detection. The optimized conditions of
mass spectrometry as follows: ion source voltage &#x02212;4.5&#x02009;kV; ion source temperature,
550&#x02009;&#x000b0;C; declustering potential (DP), 60&#x02009;V; collision energy (CE), &#x02212;40&#x02009;V&#x02009;+&#x02009;15&#x02009;eV.
Atomization gas (Gas 1, N2), heat gas (Gas 2, N2), and curtain gas pressure was
55&#x02009;psi, 55&#x02009;psi, and 35&#x02009;psi, respectively. The parent ion and the daughter ion scanning
range were 50&#x02013;800&#x02009;Da and 50&#x02013;1000&#x02009;Da, respectively. Data were collected in IDA mode,
and an automated calibration delivery system (CDS) was used to calibrate the MS and
MS/MS automatically. The data were collected using the Analyst TF 1.6.1 software for
25&#x02009;min.</p></sec><sec id="s0017"><label>2.3.10.2.</label><title>Animals and drug administration</title><p>Sprague&#x02013;Dawley (SD) male rats (Certificate NO. 181 1164, 200&#x02009;&#x000b1;&#x02009;20&#x02009;g) were provided by
the experimental animal center of Hebei Medical University. All animal experiments
followed the guidelines of the experimental animal management committee of Hebei
Medical University. The rats were housed under standard conditions (temperature,
22&#x02013;24&#x02009;&#x000b0;C, relative humidity, 45&#x02013;55%, and light, 12&#x02009;h dark 12 light cycles) for 5&#x02009;d
prior to use, and fasted 12&#x02009;h before experiment, but free to water.</p><p>The experimental rats were randomly divided into 12 groups with 3 rats per group
(groups 1 and 2, the blank blood sample groups; group 3 and 4, the blank bile sample
groups; groups 5 and 6, the blank urine and feces sample groups; group 7 and 8, the
experimental blood sample groups; groups 9 and 10, the experimental bile sample
groups; group 11 and 12, the experimental urine and feces sample groups). The volume
of gavage was 16&#x02009;mL/kg. The prepared AMF suspension was orally administered to 9 rats
of groups 7, 9 and 11 at a dose of 100&#x02009;mg/kg, and the prepared AMF-loaded
TPGS/soluplus mixed micelles was orally administered to 9 rats of groups 8, 10, and 12
at a dose of 100&#x02009;mg/kg (equal to the AMF). Groups 1, 3, and 5 were given aqueous
solution of 0.5% CMC-Na, and groups 2, 4, and 6 were given blank micelle of the same
concentration as the IGG-loaded micelle.</p></sec><sec id="s0018"><label>2.3.10.3.</label><title>Bio-sample collection</title><p><italic>Plasma samples</italic>: Approximately 300&#x02013;500&#x02009;&#x003bc;L blood was collected from
the canthus of each rat at 5&#x02009;min, 10&#x02009;min, 15&#x02009;min, 30&#x02009;min, 1&#x02009;h, 2&#x02009;h, 3&#x02009;h, 6&#x02009;h, 9&#x02009;h,
12&#x02009;h, and 24&#x02009;h after gavage. The blood samples were centrifuged at
1920&#x000d7;<italic>g</italic> for 10&#x02009;min to obtain the plasma, and then the samples were
merged.</p><p><italic>Bile samples</italic>: After intragastric administration, each rat was
subcutaneously injected with urethane solution at a dose of 1.0&#x02009;g/kg. After
anesthesia, the bile duct was intubated and the bile was collected for 24&#x02009;h.</p><p><italic>Feces and urine samples</italic>: The rats were put into a metabolic cage
after administration, fasted, but can drink freely. The urine and feces samples were
collected at regular intervals for 72&#x02009;h, and the urine and feces were merged,
respectively.</p></sec><sec id="s0019"><label>2.3.10.4.</label><title>Bio-sample pretreatment</title><p>For plasma, bile and urine pretreatment, an aliquot of 2&#x02009;mL bio-sample was vortexed
with 6&#x02009;mL of methanol for 5&#x02009;min and centrifuged for 10&#x02009;min at 4&#x02009;&#x000b0;C and
21,380&#x000d7;<italic>g</italic>. The supernatant was taken and dried under nitrogen gas at
room temperature.</p><p>For feces, 6&#x02009;mL methanol was added to 1&#x02009;g feces, ultrasonically extracted for 30&#x02009;min
at 25&#x02009;&#x000b0;C after vortexed, centrifuged at 21,380&#x000d7;<italic>g</italic> for 10&#x02009;min, and the
supernatant was taken. Repeat the above process once, and the supernatant was merged.
The supernatants were evaporated to dryness under nitrogen gas.</p><p>Before analysis, the residue was dissolved with 100&#x02009;mL methanol, vortexed and
centrifuged twice at 21,380&#x000d7;<italic>g</italic> for 10&#x02009;min. The supernatant was
injected for analysis.</p></sec></sec></sec></sec><sec id="s0020"><label>3.</label><title>Results</title><sec id="s0021"><label>3.1.</label><title>Determination of CMC</title><p>The CMC was used as an important indicator to evaluate the stability of micelles. In this
experiment, the iodine hydrophobic probe method was used to determine the CMC. As a small
hydrophobic molecule, the soluble iodine preferred located in the hydrophobic
microenvironment of the copolymer, leading to the conversion of I<sup>-</sup> to
I<sub>2</sub> in the solution. Therefore, the ultraviolet absorption of the solution
changed, and it can be measured with an ultraviolet spectrophotometer. The measured mass
ratios of TPGS and soluplus were 0: 4, 1: 3, 2: 2, 3: 1 and 4: 0. Their CMC values are
shown in <xref ref-type="fig" rid="F0001">Figure 1</xref>. It can be seen from the figure
that the CMC values of different mass ratios were very low. When the mass ratio of TPGS
and soluplus was 1: 3, the CMC value of the micelles was the lowest. Due to its low CMC,
mixed micelles have high stability and the ability to maintain their integrity even when
diluted in the blood circulation was relatively insensitive, and have a longer circulation
time compared to surfactant micelles <italic>in&#x000a0;vivo</italic> (Oerlemans et&#x000a0;al., <xref rid="CIT0027" ref-type="bibr">2010</xref>).</p><fig id="F0001" orientation="portrait" position="float"><label>Figure 1.</label><caption><p>CMC values for AMF-loaded TPGS/soluplus mixed micelles.</p></caption><graphic content-type="black-white" xlink:href="IDRD_A_1709920_F0001_B"/></fig></sec><sec id="s0022"><label>3.2.</label><title>Optimization of preparation conditions</title><p>It can be seen from the CMC results that when the mass ratio of TPGS to soluplus was 1:3,
the CMC value was the lowest, indicating that the micelle was the most stable. And it can
be seen from <xref ref-type="fig" rid="F0001">Figure 1</xref> that when the proportion of
soluplus was high, the CMC value of micelle was generally low. Therefore, according to
previous experience, the mass ratio of TPGS and soluplus was optimized in this experiment,
especially the amount of soluplus. The result is shown in <xref rid="t0001" ref-type="table">Table 1</xref>. When the ratio of AMF, TPGS, and soluplus was 1:10:30,
1:10:40, and 1:10:50, all the indexes were ideal. When the mass ratio was 1:10:30,
encapsulation efficiency of the micelle was the highest and the consumption of auxiliary
materials was relatively minimal. Therefore, in the principle of saving reagents and cost,
the final ratio of 1:10:30 was selected for micelle preparation.</p></sec><sec id="s0023"><label>3.3.</label><title>Determination of particle size, Zeta potential, encapsulation efficiency and drug
loading</title><p>Three batches of AMF-loaded TPGS/soluplus micelles were prepared according to the ratio
of 1:10:30 (AMF:TPGS:soluplus). <xref ref-type="fig" rid="F0002">Figure 2</xref> shows
that the nanomicelles had an average particle size of 67.33&#x02009;&#x000b1;&#x02009;2.01&#x02009;nm with a PDI of
0.080667&#x02009;&#x000b1;&#x02009;0.021008. The surface charge of AMF-loaded mixed micelles was neutral with zeta
potential of 0.84133&#x02009;&#x000b1;&#x02009;0.041405&#x02009;mV. And the encapsulation efficiency and drug loading
measured by HPLC were 99.18&#x02009;&#x000b1;&#x02009;0.76% and 2.47&#x02009;&#x000b1;&#x02009;0.01%, respectively.</p><fig id="F0002" orientation="portrait" position="float"><label>Figure 2.</label><caption><p>Size distribution of AMF-loaded TPGS/soluplus mixed micelles measured by dynamic
light scattering.</p></caption><graphic content-type="color" xlink:href="IDRD_A_1709920_F0002_C"/></fig></sec><sec id="s0024"><label>3.4.</label><title>Micelle stability</title><p>The AMF-loaded mixed micelles was stored at 4&#x02009;&#x000b0;C for 60 d. Particle size, PDI, Zeta
potential, and encapsulation efficiency of micelle were determined and the clarity of the
micelles was observed at 0 d, 15 d, 30 d, and 60 d. The results are shown in <xref ref-type="fig" rid="F0003">Figure 3</xref> and <xref rid="t0002" ref-type="table">Table
2</xref>. It could be seen from <xref ref-type="fig" rid="F0003">Figure 3</xref> that
there was no trend of polymerization between micelles, and Zeta potential did not change
significantly. And the results of encapsulation rate indicated that it was difficult for
micelles to self-degrade. From the appearance, micelle solution was still transparent and
clear, without precipitation. The above results indicated that the AMF micelles could be
kept relatively stable at 4&#x02009;&#x000b0;C for a certain time.</p><fig id="F0003" orientation="portrait" position="float"><label>Figure 3.</label><caption><p>The particle size and PDI of AMF-loaded mixed micelles at 4&#x02009;&#x000b0;C after storage for 60
d.</p></caption><graphic content-type="color" xlink:href="IDRD_A_1709920_F0003_C"/></fig><table-wrap id="t0002" orientation="portrait" position="float"><label>Table 2.</label><caption><p>Characteristics of AMF-loaded TPGS/soluplus mixed micelles stored for 0 d, 15 d, 30 d
and 60 d.</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/></colgroup><thead><tr><th align="left">&#x000a0;</th><th align="center">0 d</th><th align="center">15 d</th><th align="center">30 d</th><th align="center">60 d</th></tr></thead><tbody valign="top"><tr><td align="left">Size (nm)</td><td align="char" char="&#x000b1;">67.33&#x02009;&#x000b1;&#x02009;2.01</td><td align="char" char="&#x000b1;">67.71&#x02009;&#x000b1;&#x02009;1.06</td><td align="char" char="&#x000b1;">64.28&#x02009;&#x000b1;&#x02009;0.64</td><td align="char" char="&#x000b1;">62.24&#x02009;&#x000b1;&#x02009;1.76</td></tr><tr><td align="left">PDI</td><td align="char" char="&#x000b1;">0.081&#x02009;&#x000b1;&#x02009;0.021</td><td align="char" char="&#x000b1;">0.057&#x02009;&#x000b1;&#x02009;0.017</td><td align="char" char="&#x000b1;">0.067&#x02009;&#x000b1;&#x02009;0.025</td><td align="char" char="&#x000b1;">0.077&#x02009;&#x000b1;&#x02009;0.003</td></tr><tr><td align="left">Zeta potential (mV)</td><td align="char" char="&#x000b1;">&#x02212;0.84&#x02009;&#x000b1;&#x02009;0.04</td><td align="char" char="&#x000b1;">&#x02212;0.17&#x02009;&#x000b1;&#x02009;0.24</td><td align="char" char="&#x000b1;">&#x02212;0.40&#x02009;&#x000b1;&#x02009;0.20</td><td align="char" char="&#x000b1;">&#x02212;0.19&#x02009;&#x000b1;&#x02009;0.13</td></tr><tr><td align="left">EE (%)</td><td align="char" char="&#x000b1;">99.18&#x02009;&#x000b1;&#x02009;0.76</td><td align="char" char="&#x000b1;">98.96&#x02009;&#x000b1;&#x02009;0.34</td><td align="char" char="&#x000b1;">98.69&#x02009;&#x000b1;&#x02009;0.40</td><td align="char" char="&#x000b1;">98.52&#x02009;&#x000b1;&#x02009;0.40</td></tr><tr><td align="left">Clarity</td><td align="center">Clear</td><td align="center">Clear</td><td align="center">Clear</td><td align="center">Clear</td></tr></tbody></table></table-wrap></sec><sec id="s0025"><label>3.5.</label><title><italic>In vitro</italic> cytotoxicity</title><p>A549 cells were commonly used in the study of cytotoxicity. In this study, the cell
fatality rates were measured after incubated in different concentrations of AMF and
AMF-loaded mixed micelles. The results are shown in <xref ref-type="fig" rid="F0004">Figure 4</xref>. And the IC<sub>50</sub> value of AMF and AMF-loaded mixed micelles
calculated by GraphPad Prism 5 (GraphPad Software, La Jolla, CA) were 83.09&#x02009;&#x000b1;&#x02009;0.65&#x02009;&#x003bc;g/mL
and 6.11&#x02009;&#x000b1;&#x02009;0.74&#x02009;&#x003bc;g/mL, respectively. As can be seen from the figure and the calculation
results, the IC<sub>50</sub> value of AMF-loaded micelles was almost one-twelfth of that
of AMF, indicating that AMF-loaded micelles have much greater toxicity to A549 cells than
AMF. Therefore, it was speculated that AMF-loaded micelles had much higher lethality to
cancer cells than AMF, and had the potential to treat cancer. At the same time, it can be
seen that when AMF was at a lower concentration, the fatality rate of A549 cells was less
than 0, which indicating that the low concentration of AMF had a small inhibitory effect
on A549 cells, and the cells continued growing under conditions of sufficient nutrition,
so the cell concentration showed an increasing trend, and the cell inhibition rate was
less than 0.</p><fig id="F0004" orientation="portrait" position="float"><label>Figure 4.</label><caption><p>Fatality rate of A549 cell after 24&#x02009;h of treatment with (A) AMF and (B) AMF-loaded
TPGS/soluplus mixed micelles.</p></caption><graphic content-type="color" xlink:href="IDRD_A_1709920_F0004_C"/></fig></sec><sec id="s0026"><label>3.6.</label><title><italic>In vitro</italic> cellular uptake</title><p>The results of cellular uptake of AMF monomers and AMF-loaded TPGS/soluplus mixed
micelles are shown in <xref ref-type="fig" rid="F0005">Figure 5</xref>. <xref ref-type="fig" rid="F0005">Figure 5</xref> indicates that the cell uptake of AMF-loaded
mixed micelles was a time and concentration-dependent process. The cellular uptake of AMF
monomers increased obviously with the extension of time in 1&#x02013;6&#x02009;h, and the cellular uptake
of AMF-loaded TPGS/soluplus mixed micelles increased in 1&#x02013;4&#x02009;h, and remained almost
unchanged in 4&#x02013;6&#x02009;h. Moreover, the cellular uptake of AMF-loaded TPGS/soluplus mixed
micelles was significantly lower than that of AMF (<italic>p</italic>&#x02009;&#x0003c;&#x02009;.05), which was
due to the negative charge on the micelle and the negative charge on the outer surface of
the cell membrane, resulting in a lower uptake of the micelle than that of the
monomer.</p><fig id="F0005" orientation="portrait" position="float"><label>Figure 5.</label><caption><p>Time-dependent intracellular uptake in A549 cell lines for AMF and AMF-loaded
TPGS/soluplus mixed micelles. Drug amount was normalized by protein concentrations of
the cell lysates. Results are expressed as mean&#x02009;&#x000b1;&#x02009;S.D. (<italic>n</italic>&#x02009;=&#x02009;3).</p></caption><graphic content-type="color" xlink:href="IDRD_A_1709920_F0005_C"/></fig><p>As shown in <xref ref-type="fig" rid="F0006">Figure 6</xref>, it could be seen that the
cellular uptake of AMF and AMF-loaded TPGS/soluplus mixed micelles had a clear trend of
increase over time. And the cellular uptake of AMF was higher than that of mixed
nanomicelles, which was consistent with our previous results. From <xref ref-type="fig" rid="F0006">Figure 6</xref>, it can also be seen that in the samples incubated with AMF,
the morphology of the cells did not change significantly with the extension of time, and
the cells had not been lysed. But in the mixed nanomicelle incubated samples, the drug
gradually entered the cells with the prolongation of time, and the cells tended to die. By
6&#x02009;h, it can be seen that the cells had obvious lysis and the drug was gradually released.
The result also suggested that under the same drug concentration, the cytotoxicity of AMF
was significantly lower than that of AMF-loaded TPGS/soluplus mixed micelles.</p><fig id="F0006" orientation="portrait" position="float"><label>Figure 6.</label><caption><p>Cellular uptake of AMF and AMF-loaded TPGS/soluplus mixed micelles in A549 cells
observed by laser confocal microscope. Scale bar is 50&#x02009;&#x003bc;m.</p></caption><graphic content-type="color" xlink:href="IDRD_A_1709920_F0006_C"/></fig></sec><sec id="s0027"><label>3.7.</label><title>Analysis of the metabolites of AMF and AMF-loaded TPGS/soluplus mixed
micelles</title><sec id="s0028"><label>3.7.1.</label><title>Metabolites and metabolic pathway of AMF</title><p>In this study, a total of 34 metabolites of AMF were found. Metabolites were mainly
distributed in feces, including 34 metabolites (M1&#x02013;M34), and 3 metabolites were in urine
(M4, M7, and M17). No metabolite of AMF was found in bile or plasma. The result was
shown in <xref ref-type="fig" rid="F0007">Figures 7</xref> and <xref ref-type="fig" rid="F0008">8</xref> and <xref rid="t0003" ref-type="table">Table 3</xref>.</p><fig id="F0007" orientation="portrait" position="float"><label>Figure 7.</label><caption><p>Metabolic profile and proposed metabolic pathways of AMF in rats.</p></caption><graphic content-type="black-white" xlink:href="IDRD_A_1709920_F0007_B"/></fig><fig id="F0008" orientation="portrait" position="float"><label>Figure 8.</label><caption><p>Extracted ion chromatograms of all metabolites of AMF in rats.</p></caption><graphic content-type="color" xlink:href="IDRD_A_1709920_F0008_C"/></fig><table-wrap id="t0003" orientation="portrait" position="float"><label>Table 3.</label><caption><p>Summary of metabolites of AMF in rats.</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/></colgroup><thead><tr><th align="left">Metabolite ID</th><th align="center">Name</th><th align="center">Formula</th><th align="center"><italic>m</italic>/<italic>z</italic></th><th align="center">ppm</th><th align="center">R.T. (min)</th><th align="center">MS/MS Fragments</th><th align="center">Clog P</th><th align="center">Plasma</th><th align="center">Bile</th><th align="center">Urine</th><th align="center">Feces</th></tr></thead><tbody valign="top"><tr><td align="left">M1</td><td align="left">Oxidation</td><td align="left">C<sub>30</sub>H<sub>18</sub>O<sub>11</sub></td><td align="left">553.0748</td><td align="left">&#x02212;5.2</td><td align="char" char=".">5.80</td><td align="char" char=".">535.3241, 399.0500, 375.0502,
133.0282</td><td align="char" char=".">3.99244</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">+</td></tr><tr><td align="left">M2</td><td align="left">Oxidation</td><td align="left">C<sub>30</sub>H<sub>18</sub>O<sub>11</sub></td><td align="left">553.0746</td><td align="left">&#x02212;5.4</td><td align="char" char=".">6.04</td><td align="char" char=".">493.2843, 375.2439, 159.0452,
117.0346</td><td align="char" char=".">3.99244</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">+</td></tr><tr><td align="left">M3</td><td align="left">Oxidation</td><td align="left">C<sub>30</sub>H<sub>18</sub>O<sub>11</sub></td><td align="left">553.0749</td><td align="left">&#x02212;5.0</td><td align="char" char=".">6.63</td><td align="char" char=".">443.0731, 375.0507, 159.0441,
117.0345</td><td align="char" char=".">4.15118</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">+</td></tr><tr><td align="left">M4</td><td align="left">Oxidation</td><td align="left">C<sub>30</sub>H<sub>18</sub>O<sub>11</sub></td><td align="left">553.0761</td><td align="left">&#x02212;2.7</td><td align="char" char=".">6.80</td><td align="char" char=".">443.0384, 375.0494, 331.0590,
307.0583</td><td align="char" char=".">4.15118</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">+</td><td align="char" char=".">+</td></tr><tr><td align="left">M5</td><td align="left">Oxidation</td><td align="left">C<sub>30</sub>H<sub>18</sub>O<sub>11</sub></td><td align="left">553.0749</td><td align="left">&#x02212;4.9</td><td align="char" char=".">7.11</td><td align="char" char=".">443.0385, 375.0501, 133.0284,
117.0344</td><td align="char" char=".">4.36244</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">+</td></tr><tr><td align="left">M6</td><td align="left">Oxidation</td><td align="left">C<sub>30</sub>H<sub>18</sub>O<sub>11</sub></td><td align="left">553.0754</td><td align="left">&#x02212;4.0</td><td align="char" char=".">7.30</td><td align="char" char=".">417.0234, 159.0440, 117.0388,
133.0316</td><td align="char" char=".">4.36244</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">+</td></tr><tr><td align="left">M7</td><td align="left">Oxidation</td><td align="left">C<sub>30</sub>H<sub>18</sub>O<sub>11</sub></td><td align="left">553.0750</td><td align="left">&#x02212;5.4</td><td align="char" char=".">7.65</td><td align="char" char=".">467.0776, 443.0438, 375.0504,
117.0130</td><td align="char" char=".">4.38868</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">+</td><td align="char" char=".">+</td></tr><tr><td align="left">M8</td><td align="left">Methylation</td><td align="left">C<sub>31</sub>H<sub>20</sub>O<sub>10</sub></td><td align="left">551.0967</td><td align="left">&#x02212;3.0</td><td align="char" char=".">9.39</td><td align="char" char=".">493.0529, 417.0597, 399.0490,
375.0376</td><td align="char" char=".">4.64265</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">+</td></tr><tr><td align="left">M9</td><td align="left">Methylation</td><td align="left">C<sub>31</sub>H<sub>20</sub>O<sub>10</sub></td><td align="left">551.0975</td><td align="left">&#x02212;1.5</td><td align="char" char=".">9.99</td><td align="char" char=".">551.0975, 431.0744, 413.0631,
389.0634</td><td align="char" char=".">4.64643</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">+</td></tr><tr><td align="left">M10</td><td align="left">Methylation</td><td align="left">C<sub>31</sub>H<sub>20</sub>O<sub>10</sub></td><td align="left">551.0952</td><td align="left">&#x02212;5.7</td><td align="char" char=".">10.51</td><td align="char" char=".">457.0517, 431.0749, 375.0493,
331.0602</td><td align="char" char=".">5.28643</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">+</td></tr><tr><td align="left">M11</td><td align="left">Methylation</td><td align="left">C<sub>31</sub>H<sub>20</sub>O<sub>10</sub></td><td align="left">551.0978</td><td align="left">&#x02212;1.1</td><td align="char" char=".">10.82</td><td align="char" char=".">457.0529, 431.0742, 375.0488,
159.0431</td><td align="char" char=".">5.29394</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">+</td></tr><tr><td align="left">M12</td><td align="left">Methylation</td><td align="left">C<sub>31</sub>H<sub>20</sub>O<sub>10</sub></td><td align="left">551.0969</td><td align="left">&#x02212;2.7</td><td align="char" char=".">13.25</td><td align="char" char=".">483.1061, 399.0832, 321.0377,
283.0233</td><td align="char" char=".">5.53754</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">+</td></tr><tr><td align="left">M13</td><td align="left">Methylation</td><td align="left">C<sub>31</sub>H<sub>20</sub>O<sub>10</sub></td><td align="left">551.0974</td><td align="left">&#x02212;1.7</td><td align="char" char=".">14.31</td><td align="char" char=".">507.1041, 413.0503, 389/0608,
375.0588</td><td align="char" char=".">5.54265</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">+</td></tr><tr><td align="left">M14</td><td align="left">Oxidation and methylation</td><td align="left">C<sub>31</sub>H<sub>20</sub>O<sub>11</sub></td><td align="left">567.0904</td><td align="left">&#x02212;5.0</td><td align="char" char=".">6.53</td><td align="char" char=".">455.0397, 417.0597, 387.0479,
331.0578</td><td align="char" char=".">4.46777</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">+</td></tr><tr><td align="left">M15</td><td align="left">Oxidation and methylation</td><td align="left">C<sub>31</sub>H<sub>20</sub>O<sub>11</sub></td><td align="left">567.0908</td><td align="left">&#x02212;4.3</td><td align="char" char=".">7.21</td><td align="char" char=".">499.3021, 387.0500, 233.0441,
141.0680</td><td align="char" char=".">4.4689</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">+</td></tr><tr><td align="left">M16</td><td align="left">Oxidation and methylation</td><td align="left">C<sub>31</sub>H<sub>20</sub>O<sub>11</sub></td><td align="left">567.0905</td><td align="left">&#x02212;4.8</td><td align="char" char=".">7.36</td><td align="char" char=".">549.0821, 499.2736, 387.0500,
189.0547</td><td align="char" char=".">4.49093</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">+</td></tr><tr><td align="left">M17</td><td align="left">Oxidation and methylation</td><td align="left">C<sub>31</sub>H<sub>20</sub>O<sub>11</sub></td><td align="left">567.0917</td><td align="left">&#x02212;2.8</td><td align="char" char=".">8.08</td><td align="char" char=".">447.0683, 405.0583, 375.0490,
147.0438</td><td align="char" char=".">4.49585</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">+</td><td align="char" char=".">+</td></tr><tr><td align="left">M18</td><td align="left">Oxidation and methylation</td><td align="left">C<sub>31</sub>H<sub>20</sub>O<sub>11</sub></td><td align="left">567.0909</td><td align="left">&#x02212;4.2</td><td align="char" char=".">8.37</td><td align="char" char=".">451.0231, 433.0092, 409.0112,
117.0337</td><td align="char" char=".">4.71777</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">+</td></tr><tr><td align="left">M19</td><td align="left">Oxidation and methylation</td><td align="left">C<sub>31</sub>H<sub>20</sub>O<sub>11</sub></td><td align="left">567.0909</td><td align="left">&#x02212;4.2</td><td align="char" char=".">8.64</td><td align="char" char=".">499.3074, 375.0506, 351.0500,
309.0400</td><td align="char" char=".">4.80093</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">+</td></tr><tr><td align="left">M20</td><td align="left">Oxidation and methylation</td><td align="left">C<sub>31</sub>H<sub>20</sub>O<sub>11</sub></td><td align="left">567.0929</td><td align="left">&#x02212;1.5</td><td align="char" char=".">10.83</td><td align="char" char=".">473.0607, 447.0701, 405.0592,
375.0496</td><td align="char" char=".">4.80585</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">+</td></tr><tr><td align="left">M21</td><td align="left">Hydrogenation</td><td align="left">C<sub>30</sub>H<sub>20</sub>O<sub>10</sub></td><td align="left">539.0958</td><td align="left">&#x02212;4.8</td><td align="char" char=".">8.47</td><td align="char" char=".">445.0451, 413.0654, 135.0439,
117.0339</td><td align="char" char=".">3.16655</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">+</td></tr><tr><td align="left">M22</td><td align="left">Hydrogenation</td><td align="left">C<sub>30</sub>H<sub>20</sub>O<sub>10</sub></td><td align="left">539.0960</td><td align="left">&#x02212;4.4</td><td align="char" char=".">8.81</td><td align="char" char=".">539.0594, 375.0487, 309.0386,
119.0493</td><td align="char" char=".">3.16769</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">+</td></tr><tr><td align="left">M23</td><td align="left">Di-hydrogenation</td><td align="left">C<sub>30</sub>H<sub>22</sub>O<sub>10</sub></td><td align="left">541.1117</td><td align="left">&#x02212;4.4</td><td align="char" char=".">8.62</td><td align="char" char=".">497.1198, 421.0607, 353.0641,
161.0603</td><td align="char" char=".">1.37976</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">+</td></tr><tr><td align="left">M24</td><td align="left">Loss of O</td><td align="left">C<sub>30</sub>H<sub>18</sub>O<sub>9</sub></td><td align="left">521.0862</td><td align="left">&#x02212;3.0</td><td align="char" char=".">10.49</td><td align="char" char=".">503.3300, 399.0482,
375.0492</td><td align="char" char=".">5.61404</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">+</td></tr><tr><td align="left">M25</td><td align="left">N-Acetylation</td><td align="left">C<sub>32</sub>H<sub>20</sub>O<sub>11</sub></td><td align="left">579.0909</td><td align="left">&#x02212;4.1</td><td align="char" char=".">9.27</td><td align="char" char=".">537.0810, 485.0482, 493.0903,
375.0493</td><td align="char" char=".">4.96754</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">+</td></tr><tr><td align="left">M26</td><td align="left">N-Acetylation</td><td align="left">C<sub>32</sub>H<sub>20</sub>O<sub>11</sub></td><td align="left">579.0915</td><td align="left">&#x02212;3.0</td><td align="char" char=".">9.95</td><td align="char" char=".">561.0807, 537.0805,
375.0494</td><td align="char" char=".">4.97265</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">+</td></tr><tr><td align="left">M27</td><td align="left">N-Acetylation</td><td align="left">C<sub>32</sub>H<sub>20</sub>O<sub>11</sub></td><td align="left">579.0902</td><td align="left">&#x02212;5.4</td><td align="char" char=".">10.39</td><td align="char" char=".">561.3370, 537.0823, 417.0605,
375.0501</td><td align="char" char=".">5.12559</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">+</td></tr><tr><td align="left">M28</td><td align="left">N-Acetylation</td><td align="left">C<sub>32</sub>H<sub>20</sub>O<sub>11</sub></td><td align="left">579.0909</td><td align="left">&#x02212;4.1</td><td align="char" char=".">10.63</td><td align="char" char=".">561.3431, 443.0397, 399.0492,
375.0498</td><td align="char" char=".">5.12559</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">+</td></tr><tr><td align="left">M29</td><td align="left">N-Acetylation</td><td align="left">C<sub>32</sub>H<sub>20</sub>O<sub>11</sub></td><td align="left">579.0922</td><td align="left">&#x02212;1.9</td><td align="char" char=".">12.31</td><td align="char" char=".">459.0693, 417.0626,
375.0584</td><td align="char" char=".">6.02559</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">+</td></tr><tr><td align="left">M30</td><td align="left">N-Acetylation</td><td align="left">C<sub>32</sub>H<sub>20</sub>O<sub>11</sub></td><td align="left">579.0922</td><td align="left">&#x02212;1.9</td><td align="char" char=".">13.04</td><td align="char" char=".">459.0725, 417.0626, 399.0499,
349.0719</td><td align="char" char=".">6.11304</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">+</td></tr><tr><td align="left">M31</td><td align="left">Loss of O and glycine
conjugation</td><td align="left">C<sub>32</sub>H<sub>21</sub>NO<sub>10</sub></td><td align="left">578.1060</td><td align="left">&#x02212;5.7</td><td align="char" char=".">7.53</td><td align="char" char=".">417.0617, 375.0503, 306.1181,
150.0375</td><td align="char" char=".">3.71729</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">+</td></tr><tr><td align="left">M32</td><td align="left">Loss of O and
N-Acetylation</td><td align="left">C<sub>32</sub>H<sub>20</sub>O<sub>10</sub></td><td align="left">563.0960</td><td align="left">&#x02212;4.3</td><td align="char" char=".">10.88</td><td align="char" char=".">545.0876, 357.0747,
383.0528</td><td align="char" char=".">4.73389</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">+</td></tr><tr><td align="left">M33</td><td align="left">Loss of O and
hydrogenation</td><td align="left">C<sub>30</sub>H<sub>20</sub>O<sub>9</sub></td><td align="left">523.1013</td><td align="left">&#x02212;4.1</td><td align="char" char=".">10.72</td><td align="char" char=".">417.0596, 375.0485,
307.0589</td><td align="char" char=".">3.83469</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">+</td></tr><tr><td align="left">M34</td><td align="left">Internal hydrolysis</td><td align="left">C<sub>30</sub>H<sub>20</sub>O<sub>11</sub></td><td align="left">555.0918</td><td align="left">&#x02212;2.7</td><td align="char" char=".">8.44</td><td align="char" char=".">509.2884, 487.3033,
403.0834</td><td align="char" char=".">3.41608</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">+</td></tr></tbody></table><table-wrap-foot><fn id="TF1"><p>+: Detected; &#x02212;: undetected.</p></fn></table-wrap-foot></table-wrap><p>In the metabolism, metabolites were mainly distributed in feces, and none of them were
found in bile or plasma, which indicated that the bioavailability of AMF was low. The
main metabolic pathways were oxidation, methylation, oxidation and methylation,
acetylation, hydrogenation. Oxidation is its main metabolic reaction, which is related
to its antioxidant properties. The results are shown in <xref ref-type="fig" rid="F0007">Figure 7</xref>. No monoflavone was found in the metabolites of AMF, which indicated
that the biflavones formed by C&#x02013;C bonding had stable structure and were not easy to
break into monoflavone, which was different from that conjugated by ether bond (Chen
et&#x000a0;al., <xref rid="CIT0004" ref-type="bibr">2019</xref>).</p></sec><sec id="s0029"><label>3.7.2.</label><title>Metabolite analysis and metabolic pathway of AMF-loaded TPGS/soluplus mixed
micelles</title><p>Fourteen metabolites of AMF-loaded micelles were found in rats, including three in
plasma (N7, N8, and N13), six in urine (N2, N3, N5, N7, N10, and N11), and 11 in feces
(N1, N4-N12, and N14). No metabolites were found in bile, as shown in <xref ref-type="fig" rid="F0009">Figures 9</xref> and <xref ref-type="fig" rid="F0010">10</xref> and <xref rid="t0004" ref-type="table">Table 4</xref>.</p><fig id="F0009" orientation="portrait" position="float"><label>Figure 9.</label><caption><p>Metabolic profile and proposed metabolic pathways of AMF-loaded TPGS/soluplus mixed
micelles in rats.</p></caption><graphic content-type="black-white" xlink:href="IDRD_A_1709920_F0009_B"/></fig><fig id="F0010" orientation="portrait" position="float"><label>Figure 10.</label><caption><p>Extracted ion chromatograms of all metabolites of AMF-loaded TPGS/soluplus mixed
micelles in rats (A, in rat feces; B, in rat urine; C, in rat plasma).</p></caption><graphic content-type="color" xlink:href="IDRD_A_1709920_F0010_C"/></fig><table-wrap id="t0004" orientation="portrait" position="float"><label>Table 4.</label><caption><p>Summary of metabolites of AMF-loaded TPGS/soluplus mixed micelles in rats.</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/></colgroup><thead><tr><th align="left">Metabolite ID</th><th align="center">Name</th><th align="center">Formula</th><th align="center"><italic>m</italic>/<italic>z</italic></th><th align="center">ppm</th><th align="center">R.T. (min)</th><th align="center">MS/MS fragments</th><th align="center">Clog P</th><th align="center">Plasma</th><th align="center">Bile</th><th align="center">Urine</th><th align="center">Feces</th></tr></thead><tbody valign="top"><tr><td align="left">N1</td><td align="left">Oxidation</td><td align="left">C<sub>30</sub>H<sub>18</sub>O<sub>11</sub></td><td align="left">553.0774</td><td align="char" char=".">&#x02212;0.4</td><td align="char" char=".">6.04</td><td align="char" char=".">485.0855, 375.0505, 331.0602,
133.0285</td><td align="char" char=".">3.99244</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">+</td></tr><tr><td align="left">N2</td><td align="left">Oxidation</td><td align="left">C<sub>30</sub>H<sub>18</sub>O<sub>11</sub></td><td align="left">553.0774</td><td align="char" char=".">&#x02212;0.5</td><td align="char" char=".">7.30</td><td align="char" char=".">433.0500, 391.0488, 333.0409,
174.9532</td><td align="char" char=".">4.36244</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">+</td><td align="char" char=".">&#x02212;</td></tr><tr><td align="left">N3</td><td align="left">Oxidation</td><td align="left">C<sub>30</sub>H<sub>18</sub>O<sub>11</sub></td><td align="left">553.0777</td><td align="char" char=".">0.1</td><td align="char" char=".">7.65</td><td align="char" char=".">417.0641, 375.0511, 347.0530,
117.0332</td><td align="char" char=".">4.38868</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">+</td><td align="char" char=".">&#x02212;</td></tr><tr><td align="left">N4</td><td align="left">Methylation</td><td align="left">C<sub>31</sub>H<sub>20</sub>O<sub>10</sub></td><td align="left">551.0980</td><td align="char" char=".">&#x02212;0.6</td><td align="char" char=".">9.39</td><td align="char" char=".">519.0735, 431.0764, 389.0635,
375.0494,</td><td align="char" char=".">4.64265</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">+</td></tr><tr><td align="left">N5</td><td align="left">Methylation</td><td align="left">C<sub>31</sub>H<sub>20</sub>O<sub>10</sub></td><td align="left">551.0986</td><td align="char" char=".">0.5</td><td align="char" char=".">9.99</td><td align="char" char=".">533.3134, 483.0851, 389.0677,
375.0522</td><td align="char" char=".">4.64643</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">+</td><td align="char" char=".">+</td></tr><tr><td align="left">N6</td><td align="left">Methylation</td><td align="left">C<sub>31</sub>H<sub>20</sub>O<sub>10</sub></td><td align="left">551.0976</td><td align="char" char=".">&#x02212;1.5</td><td align="char" char=".">10.51</td><td align="char" char=".">483.1010, 389.0667,
190.9966</td><td align="char" char=".">5.28643</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">+</td></tr><tr><td align="left">N7</td><td align="left">Methylation</td><td align="left">C<sub>31</sub>H<sub>20</sub>O<sub>10</sub></td><td align="left">551.0980</td><td align="char" char=".">&#x02212;0.7</td><td align="char" char=".">10.82</td><td align="char" char=".">483.0173, 389.0686,
345.0753</td><td align="char" char=".">5.29394</td><td align="char" char=".">+</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">+</td><td align="char" char=".">+</td></tr><tr><td align="left">N8</td><td align="left">Methylation</td><td align="left">C<sub>31</sub>H<sub>20</sub>O<sub>10</sub></td><td align="left">551.0985</td><td align="char" char=".">0.1</td><td align="char" char=".">13.25</td><td align="char" char=".">519.0701, 483.1087,
283.0241</td><td align="char" char=".">5.53754</td><td align="char" char=".">+</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">+</td></tr><tr><td align="left">N9</td><td align="left">Oxidation and methylation</td><td align="left">C<sub>31</sub>H<sub>20</sub>O<sub>11</sub></td><td align="left">567.0934</td><td align="char" char=".">0.2</td><td align="char" char=".">7.36</td><td align="char" char=".">417.0620, 375.0516, 331.0614,
189.0559</td><td align="char" char=".">4.49093</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">+</td></tr><tr><td align="left">N10</td><td align="left">Oxidation and methylation</td><td align="left">C<sub>31</sub>H<sub>20</sub>O<sub>11</sub></td><td align="left">567.0935</td><td align="char" char=".">0.4</td><td align="char" char=".">8.08</td><td align="char" char=".">417.0601, 375.0504, 331.0607,
189.0533</td><td align="char" char=".">4.49585</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">+</td><td align="char" char=".">+</td></tr><tr><td align="left">N11</td><td align="left">Loss of O</td><td align="left">C<sub>30</sub>H<sub>18</sub>O<sub>9</sub></td><td align="left">521.0882</td><td align="char" char=".">0.7</td><td align="char" char=".">10.49</td><td align="char" char=".">503.3361, 399.0497,
375.0523</td><td align="char" char=".">5.52659</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">+</td><td align="char" char=".">+</td></tr><tr><td align="left">N12</td><td align="left">Hydrogenation</td><td align="left">C<sub>30</sub>H<sub>20</sub>O<sub>10</sub></td><td align="left">539.0985</td><td align="char" char=".">0.3</td><td align="char" char=".">8.81</td><td align="char" char=".">419.0536, 309.0391,
119.0484</td><td align="char" char=".">3.16769</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">+</td></tr><tr><td align="left">N13</td><td align="left">Phosphorylation</td><td align="left">C<sub>30</sub>H<sub>19</sub>O<sub>13</sub>P</td><td align="left">617.0467</td><td align="char" char=".">&#x02212;3.8</td><td align="char" char=".">1.67</td><td align="char" char=".">446.9946, 423.1064,
397.0020</td><td align="char" char=".">2.97424</td><td align="char" char=".">+</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td></tr><tr><td align="left">N14</td><td align="left">Loss of O and glycine
conjugation</td><td align="left">C<sub>32</sub>H<sub>21</sub>NO<sub>10</sub></td><td align="left">578.1092</td><td align="char" char=".">0</td><td align="char" char=".">7.53</td><td align="char" char=".">417.0627, 399.0467, 375.0509,
331.0601</td><td align="char" char=".">3.71729</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">&#x02212;</td><td align="char" char=".">+</td></tr></tbody></table><table-wrap-foot><fn id="TF2"><p>+: Detected; &#x02212;: undetected.</p></fn></table-wrap-foot></table-wrap><p>Among the metabolites, five were phase I metabolites and nine were phase II
metabolites. The main metabolic pathways were oxidation, methylation, oxidation and
methylation, loss of O, hydrogenation, loss of O and glycine conjugation and
phosphorylation. Methylation and oxidation were the main metabolic pathways. The results
are shown in <xref ref-type="fig" rid="F0009">Figure 9</xref>.</p></sec></sec></sec><sec id="s0030"><label>4.</label><title>Discussion</title><p>In the determination of encapsulation efficiency of AMF-loaded micelles, the micelles were
first diluted with methanol, then sonicated in water-bath, filtered by 0.22&#x02009;&#x003bc;m nylon filter
membrane, and injected for analysis. During the process, it was found that the encapsulation
efficiency of micelles prepared by the same ratio and method was unstable, and the
encapsulation efficiency of micelles prepared by different ratios was low. Because the
method of micelles preparation was the same, it was speculated that nylon filter membranes
had the sorption at different degrees to AMF. Therefore, after demulsification, the sample
was centrifuged twice but not filtered.</p><p>The CMC of different carrier ratios measured in the experiment were all low, and when the
TPGS/soluplus was 1: 3, the CMC was the lowest, indicating that the mixed nanomicelles
prepared at this ratio had good stability. AMF-loaded TPGS/soluplus mixed micelles exhibited
good stability, which was determined by the structure of micelles. AMF could be wrapped by
the two carriers in the core of the nanomicelles, which avoided the direct contact with the
matrix and prevented the degradation of drugs by gastric acid and P450 enzyme. As a result,
the drug could get into the blood to cycle in the form of micelles, and also delayed the
release of drugs, to ensure that it can play a more effective pharmacological role
(Torchilin, <xref rid="CIT0033" ref-type="bibr">2006</xref>; Xu et&#x000a0;al., <xref rid="CIT0039" ref-type="bibr">2016</xref>). The particle size of the mixed nanomicelles
prepared in this experiment was 50&#x02013;100&#x02009;nm, which was small enough. Compared with large-size
drugs, it can promote the absorption of poorly soluble drugs, significantly improve the
absorption of drugs in the gastrointestinal tract, and reduce filtration of glomeruli to
improve drug bioavailability (Wu et&#x000a0;al., <xref rid="CIT0038" ref-type="bibr">2019</xref>).</p><p>In this study, AMF-loaded TPGS/soluplus mixed micelles showed higher cytotoxicity, which
may be related to the toxicity of drug carrier TPGS to cancer cells. The anticancer activity
of TPGS was reported to be associated to its apoptosis inducing properties by the generation
of reactive oxygen species, which might be the reason for the toxicity of high concentration
of blank micelles to cancer cells. It has been reported that the toxicity of
soluplus-encapsulated drugs to cancer cells was significantly lower than that of
TPGS/soluplus-encapsulated mixed nanomicelles (Bernabeu et&#x000a0;al., <xref rid="CIT0002" ref-type="bibr">2016</xref>), which suggested that TPGS played an important role in
increasing drug toxicity. The cytotoxicity of the mixed nanomicelles was high, which may be
related to the combined effect of carrier and drug encapsulation (Bernabeu et&#x000a0;al., <xref rid="CIT0002" ref-type="bibr">2016</xref>; Ding et&#x000a0;al., <xref rid="CIT0007" ref-type="bibr">2018</xref>).</p><p>In the experiments of cytotoxicity and cellular uptake, we found that the IC<sub>50</sub>
value of AMF-loaded mixed micelles was much lower than that of AMF monomers, but its
cellular uptake was significantly lower than that of AMF. This result could be related with
the cell response (motility increment) to the antineoplastic drug over the first 6&#x02009;h of
exposure (Cagel et&#x000a0;al., <xref rid="CIT0003" ref-type="bibr">2017</xref>). Or it may be
related to the inhibition of some extracellular signaling pathways, such as NF-kappa B/MAPKs
signaling pathway and Hedgehog/Glil signaling pathway (Zhang et&#x000a0;al., <xref rid="CIT0045" ref-type="bibr">2018</xref>; Bao et&#x000a0;al., <xref rid="CIT0001" ref-type="bibr">2019</xref>),
which resulted in the abnormal growth and differentiation of cells, thus causing cell death.
Under laser confocal microscopy, it can be seen that after 4&#x02009;h, the cell morphology
incubated with mixed nanomicelles began to change significantly, and the change in cell
viability affected the absorptive capacity of cells, resulting in less cellular uptake of
mixed nanomicelles. In this case, the data confirmed that the novel AMF-loaded mixed
micelles we prepared can have a toxic effect on cancer cells in a different way compared
with most of the micelles (Bernabeu et&#x000a0;al., <xref rid="CIT0002" ref-type="bibr">2016</xref>;
Cagel et&#x000a0;al., <xref rid="CIT0003" ref-type="bibr">2017</xref>; Hu et&#x000a0;al., <xref rid="CIT0015" ref-type="bibr">2017</xref>; Ding et&#x000a0;al., <xref rid="CIT0007" ref-type="bibr">2018</xref>; Gileva et&#x000a0;al., <xref rid="CIT0009" ref-type="bibr">2019</xref>;
Shishir et&#x000a0;al., <xref rid="CIT0031" ref-type="bibr">2019</xref>). The factors such as cell
type and density, particle size, surface modifying ligands, and surface properties can also
affect cellular uptake (Wu et&#x000a0;al., <xref rid="CIT0038" ref-type="bibr">2019</xref>).</p><p>By comparing the metabolites of AMF monomers with those of AMF-loaded micelles in rats, it
was found that the metabolites of AMF monomers were mainly distributed in feces, 34
metabolites were found, only 3 metabolites were found in urine, and no metabolites were
found in plasma and bile, which indicated that AMF monomers were difficult to enter blood,
urine and bile. And most drugs passed through stomach, after intestinal metabolism, it was
excreted <italic>in&#x000a0;vitro</italic> through feces, which proved once again that AMF monomers
were water-insoluble and ester-insoluble compounds with very low bioavailability.
Metabolites in micelles are also mainly distributed in feces, with 11 metabolites and no
metabolites found in bile. However, three metabolites were detected in plasma and six in
urine. This indicated that AMF could be absorbed into blood and urine or be absorbed more
into the blood when it was prepared into micelles, and the metabolites could be detected.
The wider distribution of metabolites indicated that more drugs can enter the blood
circulation. Especially in plasma, there was a significant increase in metabolites, which
reflected indirectly that the bioavailability of AMF was improved. However, the metabolites
of micelles in feces were much less than those of monomers in feces, which illuminated that
after encapsulated in micelles, it was difficult for the AMF monomers to be metabolized by
enzymes and intestinal flora in the gastrointestinal tract, and they were directly excreted
in the form of micelles, which also reflected that the stability of AMF-loaded micelles was
good <italic>in&#x000a0;vivo</italic>. In the metabolite analysis, not only a variety of AMF
metabolites were identified but also the indirect response to the changes in
bioavailability, which was killing two birds with one stone.</p><p>In this experiment, AMF-loaded TPGS/soluplus mixed nanomicelle with good solubility and
stability, high encapsulation efficiency and drug loading, and a particle size of less than
100&#x02009;nm, which was good for oral absorption, highly toxic to cancer cells and released slowly
in the body. It can provide a good choice for the development of anti-cancer drugs.</p></sec><sec id="s0031"><label>5.</label><title>Conclusion</title><p>The solubility and the stability of AMF were poor. And literatures have reported that the
bioavailability of AMF was very low <italic>in&#x000a0;vivo</italic>. So in this experiment, the
AMF-loaded TPGS/soluplus mixed micelles were prepared, and the properties of the micelles
<italic>in&#x000a0;vivo</italic> and <italic>in&#x000a0;vitro</italic> were evaluated. The size of micelle
was small and its physicochemical properties remained relatively stable within 60&#x02009;d. In the
cytotoxicity test, the IC<sub>50</sub> value of micelles to A549 cells was much smaller than
that of monomers, which was about one-twelfth of that of monomers. And the cellular uptake
was lower than that of AMF monomers due to the negative electricity on the surface of
micelles and cell membranes. The metabolites of AMF monomer and AMF-loaded mixed micelles
were also studied. A total of 34 metabolites of AMF monomer were detected. The main
metabolic pathways were oxidation, oxidation and methylation, methylation and acetylation.
In rats, AMF was metabolized mainly through the gastrointestinal tract and then discharged
from the body. It was difficult to be absorbed into the blood and exert its pharmacological
effect and its bioavailability was low. Nevertheless, AMF-loaded mixed micelles had 14
metabolites in rats, 11 in feces, 6 in urine, and 3 in plasma. The increase of metabolites
in plasma and urine indicated that the bioavailability of AMF was improved. But it was
difficult for AMF to be metabolized by intestinal flora and various enzymes after being
encapsulated in micelles.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SM4788"><caption><title>Supplemental Material</title></caption><media mimetype="application" mime-subtype="docx" xlink:href="IDRD_A_1709920_SM4788.docx" orientation="portrait" id="d37e173" position="anchor"/></supplementary-material></sec></body><back><sec><title>Acknowledgments</title><p>The authors thank the Department of Pharmaceutical Analysis, School of Pharmacy, Hebei
Medical University for the instrument support.</p></sec><sec id="s0032"><title>Disclosure statement</title><p>No potential conflict of interest was reported by the authors.</p></sec><ref-list><title>References</title><ref id="CIT0001"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bao</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>JT</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
(<year>2019</year>). <article-title>Amentoflavone inhibits tumorsphere formation by
regulating the Hedgehog/Gli1 signaling pathway in SUM159 breast cancer stem
cells</article-title>. <source>J Funct Foods</source>
<volume>61</volume>:<fpage>103501</fpage>.</mixed-citation></ref><ref id="CIT0002"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bernabeu</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Gonzalez</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Cagel</surname><given-names>M</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
(<year>2016</year>). <article-title>Novel Soluplus((R))-TPGS mixed micelles for
encapsulation of paclitaxel with enhanced in&#x000a0;vitro cytotoxicity on breast and ovarian
cancer cell lines</article-title>. <source>Colloids Surf B Biointerfaces</source>
<volume>140</volume>:<fpage>403</fpage>&#x02013;<lpage>11</lpage>.<pub-id pub-id-type="pmid">26780253</pub-id></mixed-citation></ref><ref id="CIT0003"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cagel</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Bernabeu</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Gonzalez</surname><given-names>L</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
(<year>2017</year>). <article-title>Mixed micelles for encapsulation of doxorubicin with
enhanced in&#x000a0;vitro cytotoxicity on breast and ovarian cancer cell lines versus
Doxil((R))</article-title>. <source>Biomed Pharmacother</source>
<volume>95</volume>:<fpage>894</fpage>&#x02013;<lpage>903</lpage>.<pub-id pub-id-type="pmid">28903185</pub-id></mixed-citation></ref><ref id="CIT0004"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Feng</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>L</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
(<year>2019</year>). <article-title>UHPLC-Q-TOF-MS/MS method based on four-step strategy
for metabolites of hinokiflavone in&#x000a0;vivo and in&#x000a0;vitro</article-title>. <source>J Pharm
Biomed Anal</source>
<volume>169</volume>:<fpage>19</fpage>&#x02013;<lpage>29</lpage>.<pub-id pub-id-type="pmid">30831449</pub-id></mixed-citation></ref><ref id="CIT0005"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chiappetta</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Sosnik</surname><given-names>A</given-names></name></person-group> (<year>2007</year>).
<article-title>Poly(ethylene oxide)-poly(propylene oxide) block copolymer micelles as
drug delivery agents: improved hydrosolubility, stability and bioavailability of
drugs</article-title>. <source>Eur J Pharm Biopharm</source>
<volume>66</volume>:<fpage>303</fpage>&#x02013;<lpage>17</lpage>.<pub-id pub-id-type="pmid">17481869</pub-id></mixed-citation></ref><ref id="CIT0006"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Coulerie</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Nour</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Maciuk</surname><given-names>A</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
(<year>2013</year>). <article-title>Structure&#x02013;activity relationship study of
biflavonoids on the Dengue virus polymerase DENV-NS5 RdRp</article-title>.
<source>Planta Med</source>
<volume>79</volume>:<fpage>1313</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">23929244</pub-id></mixed-citation></ref><ref id="CIT0007"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ding</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
(<year>2018</year>). <article-title>Development and evaluation of a novel drug delivery:
Soluplus((R))/TPGS mixed micelles loaded with piperine in&#x000a0;vitro and
in&#x000a0;vivo</article-title>. <source>Drug Dev Ind Pharm</source>
<volume>44</volume>:<fpage>1409</fpage>&#x02013;<lpage>16</lpage>.<pub-id pub-id-type="pmid">29718714</pub-id></mixed-citation></ref><ref id="CIT0008"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gaucher</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Dufresne</surname><given-names>M-H</given-names></name>, <name name-style="western"><surname>Sant</surname><given-names>VP</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
(<year>2005</year>). <article-title>Block copolymer micelles: preparation,
characterization and application in drug delivery</article-title>. <source>J Control
Release</source>
<volume>109</volume>:<fpage>169</fpage>&#x02013;<lpage>88</lpage>.<pub-id pub-id-type="pmid">16289422</pub-id></mixed-citation></ref><ref id="CIT0009"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gileva</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Sarychev</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Kondrya</surname><given-names>U</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
(<year>2019</year>). <article-title>Lipoamino acid-based cerasomes for doxorubicin
delivery: preparation and in&#x000a0;vitro evaluation</article-title>. <source>Mater Sci Eng C
Mater Biol Appl</source>
<volume>100</volume>:<fpage>724</fpage>&#x02013;<lpage>34</lpage>.<pub-id pub-id-type="pmid">30948110</pub-id></mixed-citation></ref><ref id="CIT0010"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gong</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Dobes</surname><given-names>C</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
(<year>2008</year>). <article-title>Phylogeography of a living fossil: pleistocene
glaciations forced Ginkgo biloba L. (Ginkgoaceae) into two refuge areas in China with
limited subsequent postglacial expansion</article-title>. <source>Mol Phylogenet
Evol</source>
<volume>48</volume>:<fpage>1094</fpage>&#x02013;<lpage>105</lpage>.<pub-id pub-id-type="pmid">18554931</pub-id></mixed-citation></ref><ref id="CIT0011"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guo</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>X</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
(<year>2017</year>). <article-title>High oral bioavailability of 2-methoxyestradiol in
PEG-PLGA micelles-microspheres for cancer therapy</article-title>. <source>Eur J Pharm
Biopharm</source>
<volume>117</volume>:<fpage>116</fpage>&#x02013;<lpage>22</lpage>.<pub-id pub-id-type="pmid">28396280</pub-id></mixed-citation></ref><ref id="CIT0012"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guo</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Luo</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Tan</surname><given-names>S</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
(<year>2013</year>). <article-title>The applications of Vitamin E TPGS in drug
delivery</article-title>. <source>Eur J Pharm Sci</source>
<volume>49</volume>:<fpage>175</fpage>&#x02013;<lpage>86</lpage>.<pub-id pub-id-type="pmid">23485439</pub-id></mixed-citation></ref><ref id="CIT0013"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guruvayoorappan</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Kuttan</surname><given-names>G</given-names></name></person-group> (<year>2008</year>).
<article-title>Inhibition of tumor specific angiogenesis by
amentoflavone</article-title>. <source>Biochemistry Moscow</source>
<volume>73</volume>:<fpage>209</fpage>&#x02013;<lpage>18</lpage>.<pub-id pub-id-type="pmid">18298378</pub-id></mixed-citation></ref><ref id="CIT0014"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hou</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Cao</surname><given-names>B</given-names></name>, <name name-style="western"><surname>He</surname><given-names>Y</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
(<year>2019</year>). <article-title>Improved self-assembled micelles based on
supercritical fluid technology as a novel oral delivery system for enhancing germacrone
oral bioavailability</article-title>. <source>Int J Pharm</source>
<volume>569</volume>:<fpage>118586</fpage>.<pub-id pub-id-type="pmid">31377407</pub-id></mixed-citation></ref><ref id="CIT0015"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hu</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Ding</surname><given-names>R</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
(<year>2017</year>). <article-title>Improved oral bioavailability and therapeutic
efficacy of dabigatran etexilate via Soluplus-TPGS binary mixed micelles
system</article-title>. <source>Drug Dev Ind Pharm</source>
<volume>43</volume>:<fpage>687</fpage>&#x02013;<lpage>97</lpage>.<pub-id pub-id-type="pmid">28032534</pub-id></mixed-citation></ref><ref id="CIT0016"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hwang</surname><given-names>IS</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Jin</surname><given-names>HG</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
(<year>2012</year>). <article-title>Amentoflavone stimulates mitochondrial dysfunction
and induces apoptotic cell death in Candida albicans</article-title>.
<source>Mycopathologia</source>
<volume>173</volume>:<fpage>207</fpage>&#x02013;<lpage>18</lpage>.<pub-id pub-id-type="pmid">22210020</pub-id></mixed-citation></ref><ref id="CIT0017"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jain</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Kumar</surname><given-names>N</given-names></name></person-group> (<year>2010</year>).
<article-title>Self assembly of Amphiphilic (PEG)(3)-PLA copolymer as polymersomes:
preparation, characterization, and their evaluation as drug carrier</article-title>.
<source>Biomacromolecules</source>
<volume>11</volume>:<fpage>1027</fpage>&#x02013;<lpage>35</lpage>.<pub-id pub-id-type="pmid">20178378</pub-id></mixed-citation></ref><ref id="CIT0018"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jiang</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Mou</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>He</surname><given-names>H</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
(<year>2019</year>). <article-title>Preparation and evaluation of self-assembly
Soluplus((R))-sodium cholate-phospholipid ternary mixed micelles of
docetaxel</article-title>. <source>Drug Dev Ind Pharm</source>
<volume>45</volume>:<fpage>1788</fpage>&#x02013;<lpage>1798</lpage>.<pub-id pub-id-type="pmid">31500443</pub-id></mixed-citation></ref><ref id="CIT0019"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kesharwani</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Gorain</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Low</surname><given-names>SY</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
(<year>2018</year>). <article-title>Nanotechnology based approaches for anti-diabetic
drugs delivery</article-title>. <source>Diabetes Res Clin Pract</source>
<volume>136</volume>:<fpage>52</fpage>&#x02013;<lpage>77</lpage>.<pub-id pub-id-type="pmid">29196152</pub-id></mixed-citation></ref><ref id="CIT0020"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Koulouktsi</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Nanaki</surname><given-names>S</given-names></name>,
<name name-style="western"><surname>Barmpalexis</surname><given-names>P</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
(<year>2019</year>). <article-title>Preparation and characterization of Alendronate
depot microspheres based on novel poly(-epsilon-caprolactone)/Vitamin E TPGS
copolymers</article-title>. <source>Int J Pharm X</source>
<volume>1</volume>:<fpage>100014</fpage>.<pub-id pub-id-type="pmid">31517279</pub-id></mixed-citation></ref><ref id="CIT0021"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>S</given-names></name>, <name name-style="western"><surname>An</surname><given-names>S</given-names></name></person-group> (<year>2016</year>).
<article-title>Antioxidant and antiwrinkle effects of amentoflavone for cosmetic
materials development</article-title>. <source>Asian J Beauty Cosmetol</source>
<volume>14</volume>:<fpage>66</fpage>&#x02013;<lpage>76</lpage>.</mixed-citation></ref><ref id="CIT0022"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liao</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Diao</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Cheng</surname><given-names>X</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
(<year>2018</year>). <article-title>Nontargeted SWATH acquisition mode for metabolites
identification of osthole in rats using ultra-high-performance liquid chromatography
coupled to quadrupole time-of-flight mass spectrometry</article-title>. <source>Rsc
Adv</source>
<volume>8</volume>:<fpage>14925</fpage>&#x02013;<lpage>35</lpage>.</mixed-citation></ref><ref id="CIT0023"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liao</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ren</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>C</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
(<year>2015</year>). <article-title>Liquid chromatography-tandem mass spectrometry
determination and pharmacokinetic analysis of amentoflavone and its conjugated
metabolites in rats</article-title>. <source>J Agric Food Chem</source>
<volume>63</volume>:<fpage>1957</fpage>&#x02013;<lpage>66</lpage>.<pub-id pub-id-type="pmid">25415840</pub-id></mixed-citation></ref><ref id="CIT0024"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moretton</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Taira</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Flor</surname><given-names>S</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
(<year>2014</year>). <article-title>Novel nelfinavir mesylate loaded d-alpha-tocopheryl
polyethylene glycol 1000 succinate micelles for enhanced pediatric anti HIV therapy:
in&#x000a0;vitro characterization and in&#x000a0;vivo evaluation</article-title>. <source>Colloids Surf
B Biointerfaces</source>
<volume>123</volume>:<fpage>302</fpage>&#x02013;<lpage>10</lpage>.<pub-id pub-id-type="pmid">25270729</pub-id></mixed-citation></ref><ref id="CIT0025"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Neophytou</surname><given-names>CM</given-names></name>,
<name name-style="western"><surname>Constantinou</surname><given-names>C</given-names></name>,
<name name-style="western"><surname>Papageorgis</surname><given-names>P</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
(<year>2014</year>). <article-title>D-alpha-tocopheryl polyethylene glycol succinate
(TPGS) induces cell cycle arrest and apoptosis selectively in Survivin-overexpressing
breast cancer cells</article-title>. <source>Biochem Pharmacol</source>
<volume>89</volume>:<fpage>31</fpage>&#x02013;<lpage>42</lpage>.<pub-id pub-id-type="pmid">24560876</pub-id></mixed-citation></ref><ref id="CIT0026"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nishiyama</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Kataoka</surname><given-names>K</given-names></name></person-group> (<year>2006</year>).
<article-title>Nanostructured devices based on block copolymer assemblies for drug
delivery: designing structures for enhanced drug function. Polymer Therapeutics Ii:
*polymers as drugs</article-title>. <source>Conjugates Gene Deliv Syst</source>
<volume>193</volume>:<fpage>67</fpage>&#x02013;<lpage>101</lpage>.</mixed-citation></ref><ref id="CIT0027"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oerlemans</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Bult</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Bos</surname><given-names>M</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
(<year>2010</year>). <article-title>Polymeric micelles in anticancer therapy: targeting,
imaging and triggered release</article-title>. <source>Pharm Res</source>
<volume>27</volume>:<fpage>2569</fpage>&#x02013;<lpage>89</lpage>.<pub-id pub-id-type="pmid">20725771</pub-id></mixed-citation></ref><ref id="CIT0028"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pei</surname><given-names>J-S</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>C-C</given-names></name>, <name name-style="western"><surname>Hsu</surname><given-names>Y-N</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
(<year>2012</year>). <article-title>Amentoflavone induces cell-cycle arrest and
apoptosis in MCF-7 human breast cancer cells via mitochondria-dependent
pathway</article-title>. <source>In&#x000a0;Vivo</source>
<volume>26</volume>:<fpage>963</fpage>&#x02013;<lpage>70</lpage>.<pub-id pub-id-type="pmid">23160679</pub-id></mixed-citation></ref><ref id="CIT0029"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Santos</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Pereira</surname><given-names>I</given-names></name>,
<name name-style="western"><surname>Pereira-Silva</surname><given-names>M</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
(<year>2019</year>). <article-title>Nanotechnology-based formulations for resveratrol
delivery: effects on resveratrol in&#x000a0;vivo bioavailability and
bioactivity</article-title>. <source>Colloids Surf B Biointerfaces</source>
<volume>180</volume>:<fpage>127</fpage>&#x02013;<lpage>40</lpage>.<pub-id pub-id-type="pmid">31035056</pub-id></mixed-citation></ref><ref id="CIT0030"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sen Gupta</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ghosh</surname><given-names>M</given-names></name></person-group> (<year>2017</year>).
<article-title>Octacosanol educes physico-chemical attributes, release and
bioavailability as modified nanocrystals</article-title>. <source>Eur J Pharm
Biopharm</source>
<volume>119</volume>:<fpage>201</fpage>&#x02013;<lpage>14</lpage>.<pub-id pub-id-type="pmid">28648862</pub-id></mixed-citation></ref><ref id="CIT0031"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shishir</surname><given-names>MRI</given-names></name>, <name name-style="western"><surname>Karim</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Gowd</surname><given-names>V</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
(<year>2019</year>). <article-title>Pectin-chitosan conjugated nanoliposome as a
promising delivery system for neohesperidin: characterization, release behavior,
cellular uptake, and antioxidant property</article-title>. <source>Food
Hydrocolloids</source>
<volume>95</volume>:<fpage>432</fpage>&#x02013;<lpage>44</lpage>.</mixed-citation></ref><ref id="CIT0032"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Su</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Gong</surname><given-names>M</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
(<year>2019</year>). <article-title>Antidiabetic activity and potential mechanism of
amentoflavone in diabetic mice</article-title>. <source>Molecules</source>
<volume>24</volume>:<fpage>2184</fpage>.</mixed-citation></ref><ref id="CIT0033"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Torchilin</surname><given-names>VP</given-names></name></person-group> (<year>2006</year>).
<article-title>Micellar nanocarriers: pharmaceutical perspectives</article-title>.
<source>Pharm Res</source>
<volume>24</volume>:<fpage>1</fpage>&#x02013;<lpage>16</lpage>.<pub-id pub-id-type="pmid">17109211</pub-id></mixed-citation></ref><ref id="CIT0034"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ude</surname><given-names>C</given-names></name>,
<name name-style="western"><surname>Schubert-Zsilavecz</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Wurglics</surname><given-names>M</given-names></name></person-group> (<year>2013</year>).
<article-title>Ginkgo biloba extracts: a review of the pharmacokinetics of the active
ingredients</article-title>. <source>Clin Pharmacokinet</source>
<volume>52</volume>:<fpage>727</fpage>&#x02013;<lpage>49</lpage>.<pub-id pub-id-type="pmid">23703577</pub-id></mixed-citation></ref><ref id="CIT0035"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Varma</surname><given-names>MV</given-names></name>,
<name name-style="western"><surname>Panchagnula</surname><given-names>R</given-names></name></person-group> (<year>2005</year>).
<article-title>Enhanced oral paclitaxel absorption with vitamin E-TPGS: effect on
solubility and permeability in&#x000a0;vitro, in situ and in&#x000a0;vivo</article-title>. <source>Eur J
Pharm Sci</source>
<volume>25</volume>:<fpage>445</fpage>&#x02013;<lpage>53</lpage>.<pub-id pub-id-type="pmid">15890503</pub-id></mixed-citation></ref><ref id="CIT0036"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wan</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Qiao</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>X</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
(<year>2018</year>). <article-title>Structure-guided engineering of cytotoxic
cabazitaxel for an adaptive nanoparticle formulation: enhancing the drug safety and
therapeutic efficacy</article-title>. <source>Adv Funct Mater</source>
<volume>28</volume>:<fpage>1804229</fpage>.</mixed-citation></ref><ref id="CIT0037"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wei</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Guo</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>X</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
(<year>2014</year>). <article-title>Preparation, pharmacokinetics and biodistribution of
baicalin-loaded liposomes</article-title>. <source>Int J Nanomedicine</source>
<volume>9</volume>:<fpage>3623</fpage>&#x02013;<lpage>30</lpage>.<pub-id pub-id-type="pmid">25120360</pub-id></mixed-citation></ref><ref id="CIT0038"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Su</surname><given-names>X</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
(<year>2019</year>). <article-title>Repaglinide-loaded nanostructured lipid carriers
with different particle sizes for improving oral absorption: preparation,
characterization, pharmacokinetics, and in situ intestinal perfusion</article-title>.
<source>Drug Deliv</source>.</mixed-citation></ref><ref id="CIT0039"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>H</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
(<year>2016</year>). <article-title>Amphiphilic block copolymers-based mixed micelles
for noninvasive drug delivery</article-title>. <source>Drug Deliv</source>
<volume>23</volume>:<fpage>3063</fpage>&#x02013;<lpage>71</lpage>.<pub-id pub-id-type="pmid">26926462</pub-id></mixed-citation></ref><ref id="CIT0040"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yan</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Wei</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Song</surname><given-names>J</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
(<year>2016</year>). <article-title>Enhanced anticancer activity in&#x000a0;vitro and in&#x000a0;vivo of
luteolin incorporated into long-circulating micelles based on DSPE-PEG2000 and
TPGS</article-title>. <source>J Pharm Pharmacol</source>
<volume>68</volume>:<fpage>1290</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">27465923</pub-id></mixed-citation></ref><ref id="CIT0041"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Yan</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
(<year>2017</year>). <article-title>A review on the phytochemistry, pharmacology, and
pharmacokinetics of amentoflavone, a naturally-occurring biflavonoid</article-title>.
<source>Molecules</source>
<volume>22</volume>:<fpage>299</fpage>.</mixed-citation></ref><ref id="CIT0042"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yuan</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Jia</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>Y</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
(<year>2014</year>). <article-title>Study of in&#x000a0;vitro metabolism of m-nisoldipine in
human liver microsomes and recombinant cytochrome P450 enzymes by liquid
chromatography-mass spectrometry</article-title>. <source>J Pharm Biomed Anal</source>
<volume>97</volume>:<fpage>65</fpage>&#x02013;<lpage>71</lpage>.<pub-id pub-id-type="pmid">24816159</pub-id></mixed-citation></ref><ref id="CIT0043"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhai</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Guo</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>C</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
(<year>2013</year>). <article-title>Preparation and in&#x000a0;vitro evaluation of
apigenin-loaded polymeric micelles</article-title>. <source>Colloids and Surf A:
Physicochem Eng Asp</source>
<volume>429</volume>:<fpage>24</fpage>&#x02013;<lpage>30</lpage>.</mixed-citation></ref><ref id="CIT0044"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Niu</surname><given-names>JG</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
(<year>2015</year>). <article-title>Amentoflavone protects hippocampal neurons:
anti-inflammatory, antioxidative, and antiapoptotic effects</article-title>.
<source>Neural Regen Res</source>
<volume>10</volume>:<fpage>1125</fpage>&#x02013;<lpage>33</lpage>.<pub-id pub-id-type="pmid">26330838</pub-id></mixed-citation></ref><ref id="CIT0045"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>X</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
(<year>2018</year>). <article-title>Amentoflavone inhibits osteoclastogenesis and wear
debris-induced osteolysis via suppressing NF-kappaB and MAPKs signaling
pathways</article-title>. <source>Planta Med</source>
<volume>84</volume>:<fpage>759</fpage>&#x02013;<lpage>67</lpage>.<pub-id pub-id-type="pmid">29301147</pub-id></mixed-citation></ref><ref id="CIT0046"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>T</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
(<year>2019</year>). <article-title>Facile fabrication of an amentoflavone-loaded
micelle system for oral delivery to improve bioavailability and hypoglycemic effects in
KKAy mice</article-title>. <source>ACS Appl Mater Interfaces</source>
<volume>11</volume>:<fpage>12904</fpage>&#x02013;<lpage>13</lpage>.<pub-id pub-id-type="pmid">30860811</pub-id></mixed-citation></ref><ref id="CIT0047"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>C</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
(<year>2017</year>). <article-title>Soluplus/TPGS mixed micelles for dioscin delivery in
cancer therapy</article-title>. <source>Drug Dev Ind Pharm</source>
<volume>43</volume>:<fpage>1197</fpage>&#x02013;<lpage>204</lpage>.<pub-id pub-id-type="pmid">28300426</pub-id></mixed-citation></ref><ref id="CIT0048"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhaohui</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Yingli</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Hongli</surname><given-names>L</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
(<year>2018</year>). <article-title>Amentoflavone induces apoptosis and suppresses
glycolysis in glioma cells by targeting miR-124-3p</article-title>. <source>Neurosci
Lett</source>
<volume>686</volume>:<fpage>1</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">30153494</pub-id></mixed-citation></ref></ref-list></back></article>